Latest / Adventures Through The Mind / Psychedelics in Research & Practice | James W. Jesso ~ ATTMind 200
Transcript
- 0:00I don't recommend any psychedelics. I'm just telling you about these things, guys.
- 0:03Like,
- 0:03don't think that I'm recommending any of it. Should have put that at the beginning.
- 0:07Maybe I'll quickly cut this in at the beginning. Not recommending psychedelics
- 0:13here, guys.
- 0:30Hello, everyone. Welcome back to Adventures Through the Mind. Perhaps
- 0:52welcome for your first
- 0:53time. My name is James Jesso, and I'm the host here at the podcast. Normally, we do
- 1:02episodes where we
- 1:04have interviews. We have a couple of different kinds of episodes. We have
- 1:08psychedelic cafes,
- 1:09which I haven't done in a little while, where we have a group of five to seven
- 1:15different guests,
- 1:16and we do a variation on what's called the conversation cafe. It's sort of, if you
- 1:21can
- 1:21imagine having seven people all sharing the same conversation coherently. That's
- 1:27what that is.
- 1:28Normally, though, we do regular interviews, interviews with various guests
- 1:33from across the
- 1:35wide interdisciplinary field of things that are relevant and related to
- 1:39psychedelic culture,
- 1:40medicine, and research. Sometimes we also have these little clips that come out,
- 1:46sometimes 10,
- 1:47sometimes 20-minute clips from previous episodes. Those are called micros.
- 1:51I'm telling you all of this because today's episode is going to be a bit
- 1:56different. It's not going to
- 1:57be a bit different. It's going to be extremely different. I'm actually going to
- 2:01be the only
- 2:02person talking on today's episode. Normally, I'm the host. I do a little
- 2:07intro, something like this,
- 2:08and then we get in the interview. I talk a bit, but I kind of try to position myself
- 2:15such that
- 2:16I don't take a backseat to the conversation. I take a front foot forward
- 2:23kind of position,
- 2:25but it's not so much to showcase my own ideas, but to help showcase the guest. So
- 2:32I share what I think
- 2:33is relevant in the conversation where I'm inspired to, but I really try to ensure
- 2:38that it showcases the
- 2:41guest predominantly. Today is just going to be me. Sorry, I got a bit distracted by
- 2:53something coming
- 2:53on my screen. This is all going to be basically recorded in one go, other than
- 2:56if I have to take
- 2:57a bathroom break or something. So you don't have to forgive me that this is not
- 3:00as efficient and well
- 3:02cut together as normal. But today's just going to be me, not so much my own ideas,
- 3:08but a lecture that I'm
- 3:10going to give for you on psychedelics in general, sort of a larger scope of the
- 3:16landscape, the sort of
- 3:17surveying of the present landscape of psychedelics in research and practice, the
- 3:22name of this episode. And
- 3:27again, it's not so much my own ideas, as some of you might know, I have written
- 3:31multiple books are
- 3:32here on the shelf. And I have my own sort of theories on psychedelics. I'm presently
- 3:38writing my third book
- 3:39now, which takes a lot of time, way more time than I thought it was going to. And
- 3:47like all things like
- 3:48this podcast, and the costs of hosting it and running it and paying for the
- 3:53software, paying for the hardware,
- 3:54it all costs. So I guess this is my accidental lead into maybe you want to
- 4:00support the show in some way
- 4:01support me and my work, Patreon, I'll get back into that later. So leave that aside.
- 4:07But today,
- 4:08I'm going to talk about kind of just like a wider scale of review of what's
- 4:13happening with a collection
- 4:14of different psychedelics in the modern psychedelic landscape, predominantly above
- 4:21ground, not going to
- 4:22talk too much about anything happening too deep in the underground. I have quite a
- 4:27lot of awareness about
- 4:28these kinds of things. I sit on this cool middle ground where I get to speak with
- 4:34and have earned
- 4:35the trust of many above ground researchers and clinicians, and also the same for
- 4:41underground people,
- 4:42people, most of which don't end up on my show for obvious reasons of anonymity,
- 4:50confidentiality and
- 4:51security. So I'm not going to talk about the underground stuff. I'm going to talk
- 5:00about a
- 5:01small collection of some of the most predominant psychedelics that are
- 5:04presently happening,
- 5:05um, presently in the field. Uh, the intention here is for this to be a, um,
- 5:14introduction for a lot of
- 5:15you. If you're listening now, we're on episode 200. This is why I'm doing this
- 5:19thing, a special episode
- 5:20200. Um, a lot of you, this will be review, but hopefully good review. Um, I'm
- 5:26also intending for it to be
- 5:28something that people who are new to all of this can just step in and listen to it
- 5:33and get a good sort of
- 5:34solid base on what's happening in the wider field of psychedelics. I initially
- 5:40put this lecture together.
- 5:42There's going to be a slideshow in a second. It won't, you'll be able to look
- 5:45at something more than just my,
- 5:47just this mug, uh, on the video screen. Um, but I initially put this together when
- 5:52I was invited to teach a guest
- 5:54lecture at, uh, the university of Waterloo here where I live, Kitchener, Kitchener,
- 5:59Waterloo. Uh, and in
- 6:02sharing it with some of my patrons, the recording and having to kind of rush
- 6:06through the end. Cause I ran
- 6:07out of time over prepared. It turns out, um, they said, Hey, you know, why don't
- 6:12you rerecord it and put
- 6:13it up for the podcast? I mean, this was an idea I had. I was like, what do you think?
- 6:16And they were like,
- 6:17yeah, let's do it. Or let's you do it. And here we are. So we're going to get into
- 6:23that in just a
- 6:23second. Again, this is, it's not live, but I'm, I'm going to cut this as little as
- 6:28possible. So
- 6:29you're getting probably the most, uh, authentic me, I guess. Um, then normal,
- 6:37not that I'm disauthentic,
- 6:39inauthentic, disingenuous. Uh, but normally I'm trying to be much more like
- 6:44boom, boom, boom, boom,
- 6:45boom. Let's get into the podcast. Let's intro as short as possible while still
- 6:50staying relevant with
- 6:51all the information, get into the intro and, or into the interview. And today I'm
- 6:56going to let
- 6:56myself be more relaxed. Hopefully that turns out well. And it doesn't make you
- 7:02wonder like what the,
- 7:03you know, fucking hell is this guy, uh, doing, uh, why is he rambling? And I'm
- 7:10going to have edited
- 7:10that one. Cause I don't really want to create a NSF, not safe for work, NSFW
- 7:17podcast here. Um,
- 7:18I was out of psychedelics. Um, but anyways, okay. So I'm going to ramble, I'm
- 7:22going to ramble less.
- 7:22Uh, again, this is special for the 200th episode. I've only once released a lecture
- 7:27I've given
- 7:27previously was episode 135 around psilocybin and compassion. That was a
- 7:31recording of a lecture that I
- 7:32did. I believe it might've been, um, either in England or Edinburgh, Scotland,
- 7:42um, or maybe another
- 7:44city in the UK. Uh, I don't remember, but I'll put a link to that up here on the
- 7:50little show notes or
- 7:51in the, on a card here on YouTube if that's where you're watching it. So double
- 7:57check, everything is
- 7:58recording properly while I get ready to go into the, into the whole process here.
- 8:04And, uh, yeah, what do you
- 8:05say? Should we get into it? Okay. As you can see up on the screen, I got some
- 8:11slides. I've also got some
- 8:16tasty coffee. I'll be editing out all the weird mouth noises there.
- 8:21And, uh, as I said, today, we're going to be talking about psychedelics in research
- 8:26and practice.
- 8:27Now, if you're a listener to the show, you probably know a bit about me already. Uh,
- 8:33but it was in the
- 8:35lecture, uh, series or in the, uh, slideshow. So we'll go with it here and
- 8:39I'll introduce myself as
- 8:40James Jesson, the host of this podcast you're listening to now. I've written a
- 8:44couple of books.
- 8:44Like I said, they're on the, on the, um, shelf here beside me, decomposing the
- 8:49shadow lessons from
- 8:49the psilocybin mushroom and the true light of darkness. They're both discussing the
- 8:55same topics,
- 8:55which are, you know, my, a model that I created or forged out of my journeys with
- 9:02psilocybin many
- 9:03years ago, more than a decade ago, where I worked with psilocybin to bring my life
- 9:08back together
- 9:09after having, uh, made, made a mess of it and ended up in a really tough mental
- 9:17health place about 10 years
- 9:18years ago. And, um, this was long before there was a whole lot of talk about
- 9:23psilocybin for mental health
- 9:25or giving it a psychotherapeutic sort of framework to think about these experiences
- 9:29or talking about
- 9:30emotional repression or feeling processes and so on and so forth. That's a lot of
- 9:36what decomposing the
- 9:37shadow offers. It's a kind of model for understanding and engaging the experience
- 9:41for this kind of like
- 9:42personal healing, psychological, emotional, and spiritual. Um, and I put
- 9:46that together before it
- 9:47became popular before it was on CNN, before I was on Fox news, for example, uh,
- 9:52that these things were
- 9:53being talked about. And it's a very academic piece of work, scholarly essay,
- 9:57like nonfiction, the true
- 9:59light of darkness explores the same topic, but it does. So from a storytelling
- 10:04narrative, it does. So
- 10:05So while sort of sharing the living experiences, uh, the actual basically trip
- 10:11reports of journeys that I went on
- 10:13and how the decomposing the shadow model played out in how I understood experience
- 10:20and integrated these
- 10:21experiences, these journeys with psilocybin. Um, I'd like to refer to
- 10:26decomposing the shadow, kind of like the
- 10:28skeleton and the true light of darkness, kind of like the living body. Um, if
- 10:34you're more into novels,
- 10:35it'd be, you'd be more into the true light of darkness. If you're more into sort of
- 10:39like self-help style
- 10:41nonfiction, you'd probably be more into decomposing the shadow. So that's that.
- 10:46That's not what we're
- 10:47talking about today, but consider that a little plug. You could support my work in
- 10:51the podcast by buying a
- 10:52book, but today what we're going to do, these are the psychedelics we're going to
- 10:55be talking about
- 10:56today. And I'm going to, I'm going to clarify why I've got, um, ibogaine and,
- 11:01uh, sorry, MDMA and ketamine
- 11:03on there when technically they would not, in my opinion, generally qualify as a
- 11:08psychedelic, but this
- 11:09is what we're going to go through. We're going to talk about psilocybin, DMT, MDMA,
- 11:14ibogaine, ketamine.
- 11:15Now a caveat here is that, um, this is obviously a huge subject. Every single one
- 11:22of these, first off,
- 11:23this is a small subsection of the sort of potential psychedelics we could talk about
- 11:28are, you know, already have a longstanding history, um, and a lot of research behind
- 11:33them,
- 11:33such as LSD or mescaline, the ones that we're not going to talk about today. So
- 11:37not only are
- 11:37this list sort of small, small compared to the wider landscape of psychedelics,
- 11:43each of, uh, the pieces that we're going to talk about are just a small slice of
- 11:49each of these, um,
- 11:50topics. So if there's anything in this that you find interesting that you want
- 11:54expanded upon,
- 11:54you could always contact me, um, and I can send you links to maybe episodes that I've
- 11:59done that
- 12:00expands more on certain topics and so on and so forth. I'd love to engage people in
- 12:04comments. So if
- 12:04you're doing this on YouTube or Spotify and you can leave comments, I'll do my
- 12:08best to engage
- 12:09intelligently. Um, and as long as they're not like shitty comments, in which case
- 12:15I'll probably have
- 12:16like a salty, salty response for you. Um, but so keep in mind, this is a huge sub
- 12:21subject. We're
- 12:21barely going to scratch the surface today, despite the fact that we're almost
- 12:24definitely going to be
- 12:25more than two hours into this. Um, the other thing is that I'm not going to talk
- 12:30quite a lot about the
- 12:32harms that these substances can introduce, um, from psychological harms to physical
- 12:38harms, uh, to
- 12:40harms of addiction, which is present not so much in, uh, DMT and psilocybin, but,
- 12:45uh, or certainly not
- 12:46with ibogaine, but we'll talk about that, but can be present with ketamine and MDMA.
- 12:50So I'm not going
- 12:51to talk about some of these harms, but just know that as I talk about them, you
- 12:56know, like fire can
- 12:57warm a house or heat your food. It can also absolutely obliterate everything
- 13:02you've ever worked for
- 13:03until your entire life and is in literal, uh, crumbled shambles. Uh, so psychedelics
- 13:12can be like
- 13:12that too. So keep that in mind. Now, um, as we're going to get into it, here are
- 13:17the things that we're
- 13:18going to talk about. We're going to talk about in each of these molecules, we're
- 13:22going to talk about
- 13:23pharmacology, some of the history, some about the experience and some of the
- 13:27current research
- 13:28and clinical use. Um, but before we get into that, we're going to talk about
- 13:33exactly what is a
- 13:34psychedelic. The term psychedelic means mind or soul manifesting. It comes from
- 13:42the Greek psyche,
- 13:44meaning minor soul and delios meaning to reveal or, um, to manifest. So together
- 13:52you have these mind
- 13:53manifesting drugs was a fun little historical story there around how this
- 13:58term came up and a
- 13:59conversation between Aldous Huxley and Canadian psychiatrist Humphrey Osman, but
- 14:04I'll leave that
- 14:04to your Googling because I don't remember the exact quote and I didn't write it
- 14:07down. I don't want to
- 14:08mess it up, but generally that's what the term psychedelic means. And it is applied
- 14:13to a group of
- 14:15psychoactive compounds that produce altered states of consciousness or what
- 14:20you would call trips, uh,
- 14:22or journeys. Now, when I say altered state of consciousness, anything we take alters
- 14:27our state
- 14:27of consciousness. Like I am drinking a coffee right now. This is altering my
- 14:31state of consciousness. If
- 14:32I were to consume nicotine, alter my state of consciousness, cannabis, alter my state
- 14:37of
- 14:37consciousness, alcohol, alter my state of consciousness. So when I say that they
- 14:42altered our state of
- 14:44consciousness, I mean this in a pretty unique and interesting way. It is not as
- 14:48though we just sort of
- 14:49like shift into sort of different kind of like subtle nuances in our normal state or
- 14:57even more
- 14:58significant nuances in the case of alcohol, for example, I'm talking about
- 15:03entering into states of
- 15:04awareness, states of consciousness that differ at times so dramatically from our
- 15:10baseline awareness,
- 15:11baseline state of being that they become nearly unrecognizable to what we would
- 15:19experience as
- 15:20reality in baseline. So what I mean by this is there are aesthetic alterations.
- 15:26There are alterations
- 15:27in how we see things. Color can become more intense. The play of light and shadow
- 15:32can become more intense,
- 15:34things. But then visually more things can happen, what's called open or closed eyes
- 15:38visuals, where all
- 15:39of a sudden we start to see patterns or colors and empty space. Behind our closed
- 15:45eyes, we might see all
- 15:46sorts of sort of a visual play of material. It could be very metaphorical,
- 15:51like scenes, like watching a play
- 15:53unfold as if you were really there, or these highly complex sort of geometric
- 15:58images that, again, eyes close or eyes
- 16:01open. Sometimes, for example, if you see this photo here from Alex Gray, this
- 16:06painting from Alex Gray,
- 16:07one of my favorites, it's a really great example of how profound the visual
- 16:12alterations can be. This is
- 16:13a pretty good rendition of what it can be like when we're under a full effects of
- 16:19the visual alterations of
- 16:21psychedelics. Again, so that you, we can have these subjective scenes in the mind's
- 16:27eye or these patterns.
- 16:29We also have experiences where, and we'll get in a little bit more about this in a
- 16:35bit, but we have
- 16:36the experience of the normal sort of invisible walls that temper our
- 16:42emotionality, keep content
- 16:44normally reserved for the subconscious or unconscious mind sort of down. It can,
- 16:49these walls can dissolve,
- 16:51and things that we hold within us that normally we can't access or won't access
- 16:57or don't access,
- 16:58come to the forefront of awareness in ways that can be quite intense, quite sort of
- 17:03full-bodied,
- 17:05literally, but also in the sense of fully immersive. And this can be memories, like
- 17:11I said, scenes,
- 17:12and they can even at some points go beyond what feels to be personal memories. There
- 17:17are experiences
- 17:18people can have where they enter into states of consciousness where they
- 17:22experience what seems like
- 17:24memories of other people, or whole cultures, or whole species, or the whole
- 17:30arc of evolution on this
- 17:32planet as though that individual was living it out as their subjective
- 17:37experience, the entire arc of
- 17:39evolution on this planet as their subjective experience happening within a
- 17:43moment or a few
- 17:44moments or an arc in their psychedelic experience. There's also the possibility
- 17:51to, in these experiences,
- 17:53experiences have what's called a mystical or spiritual experience where one
- 17:57genuinely has the sense of
- 17:59connecting with a greater power. The sense of, say, for the term God, for example, or
- 18:07universe, or spirit,
- 18:07or etc. People have a direct, genuine, authentic, at least experientially,
- 18:15connection with this force in
- 18:17the universe, whatever it might be. And these tend to be very powerful, meaningful
- 18:24experiences.
- 18:25Another thing that psychedelics can do, which is quite interesting, is what's
- 18:32called sort of self,
- 18:34like the dissolution of the self, or ego dissolution, or ego death. Ego death is a
- 18:39pretty extreme term,
- 18:40but effectively what we're talking about here is, when I said that psychedelics can
- 18:46dissolve
- 18:47the invisible walls that temper our emotionality and keep certain internal
- 18:56content suppressed so that
- 18:57it does not necessarily too dramatically dilute or defer from our capacity to
- 19:03perceive like objective
- 19:04reality around us. One of the things that can dissolve is the sort of the model
- 19:10that's ongoingly
- 19:11operating within us that is our self-representation. The fact that I am a
- 19:17being, a James, for example,
- 19:19that has a particular sort of position of perspective. I know where I am and where
- 19:24other
- 19:25starts. I'm separate from this water bottle. I'm separate from this camera. I'm
- 19:31separate from the air
- 19:33around me, or life on the other side of the planet, or from the past or from the
- 19:36future. I'm separate from
- 19:38this and I have a clear sense of who I am. I am me. I mean, it varies from day to day
- 19:45whether or not I
- 19:46have a clear sense of what that is. But I mean, we all have this general sense, if
- 19:50we're in a healthy
- 19:51state of mind as having a solid state of mind as having a solid me. At different
- 19:57levels of intensity and at
- 19:58different doses of different psychedelics, we can have the experience of the models
- 20:03that hold that
- 20:04self-representation together dissolving away. And it feels as though I am not me
- 20:12anymore or me is gone. I am this
- 20:15bottle. I am this Mike. I am you. I am life. I am all that has ever been all at
- 20:22once.
- 20:22Um, we can have these experiences and oftentimes during the experience, this is,
- 20:29these are generally
- 20:30related to high mystical or spiritual type experiences. When we lose our sense of
- 20:36self, it goes away and we
- 20:38encounter, um, a connection with something greater than that. We are also a part of a
- 20:44part of an
- 20:44expression of and, um, the totality of this larger force, but it can also feel
- 20:52like dying because in a
- 20:54way me is dying in that sense, it's dissolving away. So that's why it
- 20:59generally gets to be called ego
- 21:00death. This is something that's quite unique to psychedelic drugs that they can
- 21:05do this. Um, and so
- 21:08we'll talk a bit about why and how they do that. Um, or at least what we understand
- 21:14about why now they do
- 21:15that. But I want to clarify that these experiences can range, even the sort of
- 21:21ego dissolution, ego
- 21:23softening, so on and so forth. It's not always so dramatic as I am dying and I am
- 21:27being, as I die,
- 21:28my sense of I is being reborn onto a larger force in the universe. It can be as
- 21:34subtle as, um, the sort
- 21:36of like the confines, the strong grips that I have around who I identify as being
- 21:42can be softened such
- 21:44that new identities, new sort of models for how I understand myself can emerge.
- 21:49Um, for example, how much I
- 21:51relate to myself with nature, which we'll talk about with respect to psilocybin in a
- 21:54bit, or how much I,
- 21:56um, hold onto a particular ideal or how much of my identity is forged into a
- 22:01particular political
- 22:02ideology. These things can shift and change like that aspect can soften.
- 22:08And so these are some of the kinds of experiences we can have. They can range
- 22:14from playful and
- 22:15recreational. They can go into the deeply therapeutic because when we talk about
- 22:19these aesthetic
- 22:20things, when we talk about these aesthetic changes, they can be very interesting and
- 22:25curious. And a lot
- 22:26of psychedelic use is very much in the recreational sort of entertainment, excuse
- 22:33me, camp. And that's,
- 22:35I don't have any issues with that necessarily. It's not necessarily the
- 22:38safest way to do it, but, um,
- 22:40there's a lot of playfulness, even in therapeutic experience can be playfulness.
- 22:44When I talk about
- 22:44therapeutic, this is where with experiencing these memories or these old
- 22:48feelings or connecting with,
- 22:50um, you know, a new way of understanding ourselves, or it allows us to undergo
- 22:56these, what people often
- 22:58call is like deeply healing experiences. And in the context of therapeutic support,
- 23:03and by this,
- 23:03I mean, a therapeutic facilitator or a ceremonial facilitator, we can deepen into
- 23:09those therapeutic
- 23:10aspects. It could also go as far as being profoundly spiritual. Like I said before,
- 23:15um, they can range as
- 23:17well from acutely pleasant, like really pleasant, even like sexually, sensually
- 23:23pleasant to extremely
- 23:25unpleasant, heightened states of anxiety, fear, panic, terror, hell without escape.
- 23:33This is how far,
- 23:34you know, like merging into like sex, sensual, orgasmic union with the universe
- 23:41as we sort of like
- 23:42explode into everything in life. And it's absolute beauty to hellish, you know, like
- 23:49hell with no escape,
- 23:51like infinite demonic suffering. Like they can go that far, um, in their sort of
- 23:59valence.
- 24:00They can also have positive or negative consequences. We can have a really
- 24:05challenging experiences that have
- 24:07really positive consequences in our lives. We can have really positive experiences
- 24:11that have neutral
- 24:11consequences. We could have experiences that have negative consequences, such as
- 24:15harms that could come
- 24:16from it or confusing us or just like, you know, so there's so much variability here
- 24:22and there, you know,
- 24:25whether or not the positive or negative outcome is not defined by the acute sort
- 24:29of experience. Like I said,
- 24:31negative outcomes can have positive consequences. Um, and this is something
- 24:35else that's unique to
- 24:36psychedelics, which is that the effects are significantly mediated by contextual
- 24:42factors.
- 24:42What that means is that, you know, if I take a Tylenol or I, if you know, maybe
- 24:47it's paracetamol or
- 24:48wherever else, if I take a set of metafin, I know that I take this drug, it's going
- 24:53to have a particular
- 24:53effect. There might be some variation depending on my unique sort of genome and
- 24:59my physiology as to how
- 25:01it's going to affect me. But for the most part, it's going to be pretty stable. I'm
- 25:04going to take
- 25:05Tylenol. It's going to have a pain relieving effect, or I'm going to drink
- 25:09alcohol and it's going to have
- 25:11an inebriating effect that is pretty, you know, I might be more playful or more
- 25:18depressed depending
- 25:19on how I'm feeling and where I'm at. But for the most part, it's pretty stable with
- 25:23psychedelics,
- 25:24the context, which would be our internal context or mindset context, what we're
- 25:30coming in with,
- 25:31what we believe about the psychedelics and narratives we have about these drugs or
- 25:35what they can offer us,
- 25:36concepts we have on board to understand our experiences, the feelings we're going
- 25:40in with,
- 25:41the history that we're going into with, that would be our internal context. And
- 25:46the external context,
- 25:47like where we are, who we're with, what's present or absent in the room, and then
- 25:52also the context of
- 25:53dose, the variability of how intense and like far out the experience can take us
- 25:59also is can be
- 26:01significantly mediated by how much the dose is. So these three factors, which are
- 26:06often called set
- 26:07setting and dose, they can have such wide ranging differences that between
- 26:12different, you know,
- 26:13outside of some universal characteristics that are pretty similar between each
- 26:16molecule,
- 26:17different people can have widely different experiences on different, on totally
- 26:23journey days. So it's heavily mediated by context, whether or not it's going to be
- 26:29profoundly spiritual
- 26:30or just playful and recreational is something that you can reasonably sort of
- 26:35modulate by the context
- 26:37that you take it in. Now, that's not a hard line. Sometimes people take mushrooms
- 26:42at a festival and they
- 26:43meet God and their lives are changed. And sometimes people go into a ceremony to
- 26:47have a deeply spiritual
- 26:48experience and all they get is just like rehashing of all the reels that they
- 26:53consume three or four days
- 26:54before. Um, so it's not a hundred percent definite, but it's true that they're
- 27:01highly mediated by context,
- 27:03unlike other drugs. Um, the other thing that is interesting about psychedelics
- 27:09that is part of
- 27:10what, and we'll talk about in a second, defines them as psychedelics is that they
- 27:14tend to target
- 27:15predominantly, or at least the psychedelic effects seems to predominantly, um, be
- 27:21through their impact
- 27:22on what's called the serotonin 5-HT2A receptors. And that the modulation of
- 27:27those receptors seems to be
- 27:28responsible for the psychedelic effects. Um, such as, like I said, I think I said,
- 27:34alterations and
- 27:34um, aesthetic experience. So patterns, colors, also feelings. Part of what that
- 27:40is, is an increase of
- 27:42sensory awareness. Um, again, this is totally off the cuff. So if I'm rambling,
- 27:47you're going to have
- 27:48to forgive me. I drank a big coffee, afraid that I wouldn't say to enough, and
- 27:51I might be saying too much.
- 27:53Um, but so that's a general sense of what is a psychedelic. Now, another question is
- 27:59like,
- 27:59what makes them so interesting to research? I mean, maybe you already know
- 28:04this. Um, again,
- 28:05I gave this talk for, I think a second year, um, cognitive neuroscience students.
- 28:09So, um,
- 28:11I broke it down into three different sort of avenues or three different domains that
- 28:18they would
- 28:18be interested. That makes them interesting to research. Um, one is that from the
- 28:22perspective
- 28:22of cognitive neuroscience, when we have a molecule that we can give to somebody and
- 28:28we can reliably
- 28:30take them into extremely different states of consciousness, we're able to a better
- 28:37understand
- 28:37those states, like what is happening in the brain when those states are being
- 28:41triggered. But we could
- 28:42also get a better understanding of baseline consciousness. If we know what it
- 28:48is that's
- 28:49triggering these significant changes into altered states of consciousness, we get a
- 28:53better understanding
- 28:54of what is involved in sustaining baseline consciousness. So we get a better
- 28:59understanding
- 28:59of, um, what would be called the neurological correlates of consciousness.
- 29:03It correlates neurological as it's in the brain correlates because it's correlated.
- 29:09I imagine some of you have a more physicalist perspective, or maybe some of
- 29:13you have a more
- 29:14idealist perspective, but you know, where the cause and effect is here. Like does
- 29:19brain cause
- 29:20consciousness is, is conscious consciousness cause brain. That question
- 29:24is irrelevant here. Um,
- 29:26or while it's not irrelevant, but it's not what I'm speaking to here. When I say
- 29:29neurological
- 29:30correlates of consciousness, what we know is regardless of what sort of direction
- 29:33the causal
- 29:34flow is going. When we alter the brain, we see things happening in the brain. When we
- 29:42see baseline
- 29:43states, when we see psychedelic states, different things are happening in the
- 29:46brain. Certain functions
- 29:47and firing patterns are correlated with baseline correlated with psychedelic
- 29:51states. So that's why
- 29:53we call them the neurological correlates of consciousness, which of course can be
- 29:57incredibly
- 29:58interesting for people to research, giving us a better understanding of the brain of
- 30:04awareness of
- 30:05consciousness and of, in many ways like healing and therapy. When we look at how
- 30:10these can be utilized in
- 30:11therapy. Now, from a philosophical perspective, we have these drugs that can
- 30:17reliably trigger such
- 30:18incredibly different states of awareness that it creates an opportunity to
- 30:24philosophically
- 30:25through experimentation, uh, enter into explore, like, what is consciousness? What
- 30:32is this place?
- 30:33Where are we going? What does it say about where we are when we can take a drug to go
- 30:37there? And we can have
- 30:39these like interesting explorations of, you know, philosophically, um, the human
- 30:45experience through the
- 30:47analysis of the subjective reports or from the subjective experiences of taking
- 30:52psychedelics.
- 30:53Now, from a therapeutic perspective, what is interesting about their research here
- 30:58is that
- 30:58many like anecdotal reports and ongoing sort of like clinical and experimental,
- 31:05um, studies are showing
- 31:08that these drugs used in, you know, certain contexts, not to say that this
- 31:14doesn't happen outside of those
- 31:16contexts, but we can increasingly say that use in these particular contexts, these
- 31:20substances can reliably,
- 31:22um, treat or have potential treatment for many different psychiatric and
- 31:29neurodegenerative disorder
- 31:31disorders that we otherwise have very poor treatments for, or, um, we have no
- 31:37treatments for.
- 31:39So in that sense, they're incredibly interesting to research for these three
- 31:42reasons. Now, um,
- 31:44unfortunately they're also illegal.
- 31:46And I say this, unfortunately, because I personally am more inclined to believe in,
- 31:54uh, these substances
- 31:56being at minimum decriminalized, if not legalized. Although that has that
- 32:02perspective for me is really,
- 32:04um, it's highly dependent on public education. I think basically any and all
- 32:12drugs could be pretty
- 32:13much legal and accessible to people. If we had good education and good sort of
- 32:18healthcare around helping
- 32:20people make positive, um, uh, choices, not just in harm reduction, but benefit
- 32:25optimization,
- 32:26what, uh, Emmanuel Spheros used to call being drug positive, um, as a correlation
- 32:32to sex positive.
- 32:33Um, but that's, that's nonetheless, the point is, is that these drugs were widely
- 32:39made illegal on the
- 32:41federal level in the United States. Um, in, despite the fact that in the sixties,
- 32:46not all of them, but
- 32:47especially, uh, substance like LSD, uh, were becoming incredibly and, and MDMA
- 32:53later in the eighties,
- 32:54but they became incredibly, um, popular with research and with clinicians because
- 33:01of these effects.
- 33:02But unfortunately, so the story goes, uh, the kind of like quote escaping the lab of
- 33:11LSD and the impact
- 33:13that had on the counterculture and particularly anti anti-war movement in the
- 33:18sixties, um, resulted in
- 33:21President Nixon, uh, signing a, the comprehensive drug abuse and prevention,
- 33:26drug abuse prevention and
- 33:27control act in 1970, criminalizing these drugs, which then spread internationally
- 33:34through the UN
- 33:34convention of psychotropic substances back in 1971. Most of them widely remain
- 33:40illegal today. Um,
- 33:43outside of certain circumstances, um, basically because modern research managed
- 33:50to sort of
- 33:50open the door on doing the research and it is increasingly showing these incredible
- 33:55benefits for
- 33:56therapy that there is renewed access being gained, not just through, um, research
- 34:04settings,
- 34:04but also through clinical settings in different countries. So basically the
- 34:08evidence that we're
- 34:09building here for safety and efficacy in therapeutic treatment is making for
- 34:13greater, uh, inclusion or
- 34:14access through the, what's called like the medical track, the medical legalization
- 34:18track.
- 34:18For example, various states in the USA have different sort of states and even
- 34:24cities have
- 34:25different laws about accessing these drugs, such as decriminalizations in
- 34:28Denver, Colorado, or
- 34:30a state level of legislation that allows for what's called psilocybin services in
- 34:35Oregon,
- 34:36Australia, um, made, I believe psilocybin therapy legal ish. I don't know the
- 34:43details on that in 2023,
- 34:44although approval on that is quite slow. And here in Canada, there's, um, it's not
- 34:49federally legal or even
- 34:51provincially legal or any of that, but we do have a growing movement where access
- 34:56for psilocybin
- 34:57therapy in particular for, um, patients as well as providers, um, are being, uh, made
- 35:03available
- 35:03through what's called the section 56 special access program, where drugs that
- 35:08aren't approved
- 35:10can be given to people, um, in dire circumstances. So we have that happening
- 35:18for greater access,
- 35:19despite them remaining illegal. On top of that, we have a strong decriminalization
- 35:24movement. I already
- 35:25mentioned Denver, Colorado, for example, but there are other cities that have
- 35:28decriminalized it where
- 35:29you're just not going to get in trouble for having it, but it has also created the
- 35:34presence of a gray
- 35:36market. So, um, I don't, the term black market obviously has like weird racial
- 35:41connotation. So I
- 35:42prefer kind of like legacy market or underground market. This is when you like
- 35:46text your drug dealer
- 35:48and they get you the illegal drugs. That would be like the underground market. Um,
- 35:52and then if you say
- 35:53like the above ground market, you've got, you can walk into a store and buy it. Do
- 35:57you imagine like
- 35:58every time you go to the pharmacy, you are operating in the above ground market,
- 36:02whether it's over the
- 36:03counter or behind the counter, um, you're operating in the above ground market. The
- 36:08gray market is where
- 36:09things are still pretty illegal, but you don't have to like touch, text your drug
- 36:13dealer or do anything
- 36:13too sketchy to get it. So for example, despite it being illegal, there are a lot
- 36:18of places that you
- 36:20can buy, um, micro doses online or just straight up by mushrooms, like mushroom
- 36:25dispensaries, or I keep
- 36:27getting targeted ads on, on Facebook, which might be scams, but like targeted
- 36:31ads that are literally
- 36:32trying to sell me just like pure crystal MDMA, uh, right on the regular open web.
- 36:37Um, and there's
- 36:38even physical mushroom dispensaries. There are some in Vancouver, Canada, for
- 36:43example,
- 36:43there used to be multiple ones in our city, but the, um, but the city was
- 36:49wasting tens and tens of
- 36:51thousands of, uh, public dollars, closing it down over and over again, despite that
- 36:55it was causing
- 36:56absolutely no harm whatsoever in the city, uh, until I guess they stopped reopening
- 37:01it. Personally,
- 37:02I think that was a massive waste of public funds unnecessary, but that's trying not
- 37:07to get too
- 37:07much on my soapbox there, but nonetheless, here we are. They are illegal mostly in
- 37:14most places,
- 37:15except in certain circumstances and progressively that is changing. Um, now
- 37:21earlier I had mentioned that,
- 37:22um, between the substances that we're talking about here today, we've got, um,
- 37:29you know,
- 37:29psilocybin, um, MDMA, ketamine, DMT, ibogaine, that I said, some of them aren't
- 37:37really psychedelics,
- 37:38but I'm grouping them all under psychedelics. The reason I'm doing that,
- 37:42and I'm, I'm taking a sort
- 37:43of, uh, taken, uh, taking this from, um, Nolan Williams, who's a researcher at, I
- 37:51believe Stanford
- 37:52medicine. He was on the podcast to talk about ibogaine. I'll mention him again a
- 37:56bit later.
- 37:56Um, and he had mentioned this idea of splitters versus lumpers where a splitter
- 38:02would say, well,
- 38:03a psychedelic technically is only, uh, a psychedelic, which are classical
- 38:08psychedelics
- 38:08are the ones that, um, affect the serotonin five HD to a receptor. Those are
- 38:14psychedelics.
- 38:14Anything that doesn't have its primary consciousness altering effect through
- 38:19that,
- 38:19that sub receptor is not technically a psychedelic. MDMA would not count. Uh,
- 38:24ketamine would not count.
- 38:25Ibogaine would not count. Lumpers would say, well, you know, sure, technically
- 38:30yes, but we could all
- 38:32just kind of, we can just generally just call them psychedelics and we'll just call
- 38:35it psychedelic
- 38:36research. And it's not so egregious to sort of lump them in together because they
- 38:42all kind of like
- 38:43sit in the same movement at least. And they have similar enough experiences to
- 38:48say, let's just call
- 38:49them psychedelics. I am more inclined to be on the splitter side of things, but for
- 38:54the purpose of
- 38:54this lecture, we're doing the lumber side. Now that said, uh, the first substance
- 39:04we're going to talk
- 39:04about today is technically under the splitter terminology, a psychedelic. We're
- 39:11going to be
- 39:12talking first about silocybin or for phospholar. Oh my goodness. For
- 39:19phosphoroxy NM-dimethyltryptamine.
- 39:23Um, so, uh, psilocybin is the active ingredient in what is called magic
- 39:30mushrooms. Uh, I like that
- 39:33term. Some people don't, there are more than 200 different species of magic
- 39:38mushrooms that exist
- 39:40around the globe and every continent except for Antarctica, as far as I know,
- 39:44uh, growing wild,
- 39:45in a range of different, um, mushrooms, not just one genus, for example, multiple
- 39:51different genuses
- 39:52that developed or got the, um, the, what's called the biosynthetic pathway for
- 39:58producing the, uh, molecules
- 40:00that include psilocybin called siloids, um, that produce these effects, got them
- 40:07through horizontal
- 40:08gene transfer, like millions of years ago. This is crazy. So anyways, it's, it's very
- 40:11widespread across
- 40:13the entire globe, across a bunch of different species and different, um,
- 40:17genuses of mushrooms.
- 40:18The one that I understand to be the oldest would be, and the most prolific would be
- 40:23psilocybe genus. And they developed the biosynthetic pathway for the production of
- 40:29siloids, such as
- 40:30psilocybin back like 65 million years ago, like long ass time. Um,
- 40:38psilocybin is a tryptamine alkaloid. Now I'm going to, I'm really heavily leaning
- 40:41into my notes here
- 40:42because I'm not a organic chemist. So I'm going to explain this the way I understand
- 40:46it, but you have
- 40:46to keep in mind that I'm not a much of a professional, uh, or authority on this,
- 40:51but a tryptamine
- 40:53alkaloid. So first off an alkaloid is a nitrogen containing compound that is often
- 40:57biologically active,
- 40:58which means it interacts with our nervous system. Common alkaloids that I'm sure
- 41:03many of you are,
- 41:03are, uh, have, or are presently under the influence of would be something like
- 41:08caffeine or nicotine.
- 41:09Other alkaloids include things like morphine and queen quinine, which is the,
- 41:15um, compound I believe
- 41:17they used to treat malaria or prevent malaria. Tryptamines are a family of
- 41:23alkaloids. Their
- 41:24molecular structure is built around a particular shape called the indole ring
- 41:29system. You can consider
- 41:31where, um, like different tryptamines as being like slight variations on this ring
- 41:37system, this indole,
- 41:38um, ring system, like jazz variations on a theme. And these variations can range
- 41:44dramatically and create
- 41:45different effects on the mind and nervous system from, uh, complete inactivity to a
- 41:50thousand fold
- 41:51increases in potency. What I mean by this is you could have a basic indole ring
- 41:55structure, a tryptamine
- 41:56alkaloid that looks almost identical, um, to another one, but a slight variation
- 42:03creates,
- 42:04like I said, complete inactivity or a thousand fold increases in potency.
- 42:08Additionally, the tryptamine
- 42:10alkaloids core structure tends to be very similar to serotonin, which is why
- 42:15classical psychedelics,
- 42:16which are those that would be a splitters, uh, group of psychedelics, those that
- 42:21affect the 5-HT2A
- 42:23receptor are generally considered, um, or often described as serotonin analogs.
- 42:28Um, psilocybin is a pro-drug, which means that when we, it's a pro-drug to silicin
- 42:37or for hydroxy and then
- 42:39DMT, 4-H-O-D-M-T, a pro-drug means that we take this drug and it turns into another
- 42:47drug.
- 42:47So psilocybin doesn't actually do anything to you in your brain. So, oh my God,
- 42:53psilocin does.
- 42:54So you take psilocybin, it converts to psilocin, psilocin creates these effects
- 42:59that we know as
- 43:00psychedelic, um, as the psychedelic effects of psilocybin. And well, what are
- 43:05those effects?
- 43:06Like I said, it binds predominantly to a 5-HT2A receptor, which changes firing
- 43:11patterns in neural
- 43:12networks. So our brain is a sort of incredible system of multiple networks of
- 43:19relationships and
- 43:20firing patterns that all sort of work in tandem with each other. And when we alter
- 43:24those firing
- 43:25patterns, when we alter the functioning of those networks, we alter experience, we
- 43:29alter consciousness.
- 43:29Theoretically, you could also say that when we alter our states of awareness,
- 43:34we're altering those firing patterns. Um, at least from the sort of theory that is
- 43:40out on
- 43:41how these things are affecting and changing consciousness. Um, psilocybin is
- 43:45said to affect
- 43:46what's called the default mode network, the DMN. The default mode network is
- 43:52basically what's happening
- 43:53where you are in your brain when you're not doing anything in particular. It is
- 43:58the sort of like
- 43:59random thought generations that just unfold when you're not particularly
- 44:04engaged in like what's
- 44:05called like the task positive network. I'm in the task positive network right now by
- 44:11talking to you,
- 44:11I'm engaging in a task. Um, if I were to just sit here and let my mind wander, I
- 44:16would be entering into
- 44:17the default mode network. Um, the salience network is what jumps us between it. I
- 44:23believe
- 44:23when we, um, so basically it's what's happening when we're at rest and we have
- 44:29no explicit cognitive
- 44:30tasks. The default mode network kind of shapes our sense of time or sense of space
- 44:35and our sense of
- 44:36self. When we imagine like what is our, what it is to feel like to be me. If I ask
- 44:42that question
- 44:43and we go into task positive exploration of that question, we might come up with a
- 44:46lot of answers or
- 44:48maybe not as many answers as we hope we could. Um, but when we're just at rest,
- 44:53it's like the thoughts,
- 44:55feelings, emotions, it's the things that just run through our mind that kind of
- 44:58like they become
- 44:59the background of experience that becomes the sort of like not always consciously,
- 45:04not always, uh,
- 45:06consciously aware aspects of our mind that we define and experiences ourselves.
- 45:12Um, that default mode network, our sense of self right also influences the self
- 45:19other relationship
- 45:20because our defined sense of space, time and self influences the parameters, the
- 45:25sort of like
- 45:26dividing lines by which then all things become other past self, all things become
- 45:31other. Okay. So
- 45:33when, uh, we have this reduction in the default mode network that psilocybin seems
- 45:39to do,
- 45:39that is where we start to get those effects that I talked of earlier. We get,
- 45:44um, the increases in
- 45:45sensory awareness. We get the changes in sort of aesthetic, but we also get the
- 45:49sort of dissolution
- 45:50of those invisible walls that allow certain things to come up because the
- 45:54default mode network also kind
- 45:55of works to hold things in, in a particular way. We get things that arise,
- 45:59we get changes in our sense
- 46:00of self. We get even the experience of our sense of self dissolving away. Um, part of
- 46:08what happens when
- 46:09it's changing the sort of firing pattern. So it alters blood flow in the brain.
- 46:14Silosin does
- 46:15it changes firing patterns such that the, the sort of normal direction that things
- 46:21would flow through
- 46:23sensory experience into conscious awareness and understanding of like models
- 46:26and like what we
- 46:28understand things to be and what we perceive them to be and what they are
- 46:32tangibly in our sensory
- 46:33experience. That sort of normal flow changes and parts of the brain that
- 46:39normally don't communicate
- 46:40with each other, start to communicate with each other. Um, and certain aspects of the
- 46:46brain that
- 46:46normally would be sort of like sub perceptual or like sort of outside of
- 46:51conscious awareness,
- 46:52because of the change in these blood flow and firing patterns between the
- 46:56communication between
- 46:57these networks, they start to sort of take a stronger or more dominant place in our
- 47:02conscious
- 47:03awareness. So I have this picture up here, uh, which is from the homological
- 47:10scaffolds of brain
- 47:11functional networks, a paper from 2014, where you can see on the left is them sort
- 47:16of creating a, uh,
- 47:18pretty visual representation of the sort of, uh, the sort of network
- 47:22intercommunications between networks
- 47:25functioning in the brain sober. That would be a or the left and then on psilocybin,
- 47:30which are
- 47:31psilocybin, psilocybin, um, in B and you can see, wow, that's a lot more
- 47:37communication.
- 47:38Um, now historically, um, discussing psilocybin histories is way too big to do
- 47:46it justice. But,
- 47:46uh, what we can say is that psilocybin containing mushrooms, at least were
- 47:52brought to the modern eye,
- 47:54thanks to Valentina and R Gordon-Wasson back in 1955. They were introduced to, I
- 48:01believe it was
- 48:02psilocybin Mexicana or psilocybin, um, um, masatepic, or maybe it's, um,
- 48:10celorescence. It doesn't matter.
- 48:11They were introduced to these, um, psilocybin containing mushrooms through
- 48:16the indigenous healers,
- 48:17Maria Sabina, um, during some mycological research they were doing in Southern
- 48:22Mexico. Now,
- 48:23the story there is just so interesting and so complex and at times quite contentious.
- 48:30Um,
- 48:31and I would highly recommend you look into it. It is very interesting. Um, but
- 48:37nonetheless,
- 48:38that is how we became popularly aware of psilocybin containing mushrooms, because
- 48:43I believe this was a violation of his agreement with Maria Sabina, but
- 48:47Wasson then went out and wrote a article about this showing her pictures. This is
- 48:52the picture in the middle
- 48:53there and other information in the life magazine, which exploded it around the
- 48:57world.
- 48:58Now, historically, what we know about their use in Mexico is that they have been
- 49:05psilocybin
- 49:06containing mushrooms have been historically used by the indigenous people
- 49:09in Mexico. What we know now,
- 49:11predominantly the Mazatec, uh, Mazatec people who are at least still using it, or
- 49:16at least we're using
- 49:17it in recent memory, but could go back as far as the Aztec people who called them
- 49:22Teonatacatl, meaning the
- 49:24flesh of the gods, perhaps even as far back as the Olmec people, which are very
- 49:29like ancient,
- 49:30the ancient peoples of the land that we now call Mexico. Um, the indigenous use of
- 49:36these, this mushroom
- 49:37was basically pushed underground, uh, due to suppression by way of the Spanish
- 49:42colonizers,
- 49:43which obviously is not good in a lot of ways, but is complex because, you know, it
- 49:49wasn't necessarily
- 49:50without cause. Like the Aztec people were using these mushrooms and ceremonies that
- 49:54included basically
- 49:56human sacrifice while under the influence. And I'm sure there was a lot of use that
- 49:59was not so
- 50:00awful, uh, not so involved with such awful stuff. Um, but the use of mushrooms and
- 50:08human sacrifice
- 50:09and violence, it was pretty, uh, present at least in the Aztec people. So the part
- 50:15of what pushed the
- 50:16suppression of their use by way of the Spanish colonizers and, um, the sort of
- 50:22like expectations
- 50:23of, I don't know if it was the king or the queen of Spain at the time. And they're
- 50:26sort of like
- 50:26Christian ideals probably not great in some ways also did have an influence on
- 50:32suppressing human
- 50:33sacrifice, which is probably good. Um, but don't cancel me. I don't know. Right. Um,
- 50:38I'm open to different, different perspectives on that. Uh, so on the left,
- 50:43you see a, um, a
- 50:45depiction of a statue, which was found in a tomb. I don't remember, uh, but in
- 50:49Mexico, and it is the,
- 50:50the, the God, you know, if the part of me, I don't speak, I believe now wall, which
- 50:56is the name
- 50:56of the line or the language here. And according to Wikipedia, he was the God of
- 51:01beauty, love,
- 51:02passion, sex, sexuality, fertility, art, song, dance, music, painting, writing,
- 51:08games, playfulness,
- 51:09nature, vegetation, and flowers in Aztec mythology. Like dude was a renaissance
- 51:15man. It's not the right
- 51:16term. Um, but, uh, uh, clearly quite a dynamic, uh, rep representation, dynamic
- 51:24God. Um, he was also
- 51:25considered to be the patron of homosexuality and me and male prostitutes.
- 51:30Um, but he also considered
- 51:32to maybe have been specifically sort of a representation of working with
- 51:37psychoactive
- 51:38plants because this statue that you see here has depictions of different
- 51:42psychoactive plants.
- 51:44Specifically, it's got, let's see what's got the psilocybin, uh, mushroom cap. It's
- 51:48got the morning glory,
- 51:49which contains the pre, uh, chemical, very similar to LSD, um, and, uh, the, the
- 51:56nicotine flower.
- 51:58And, uh, I'm not sure those other ones. So that being said, um, as to the history of
- 52:05psilocybin,
- 52:05we also have what's called the stoned ape theory contentious, interesting timeline.
- 52:11I think it's pretty
- 52:12good. You know, if psilocybin has been around 65 million years, but effectively,
- 52:16as you can see on the
- 52:17picture from on the right also from Alex gray is, um, the idea that, uh,
- 52:26psilocybin mushrooms were involved in the development or the evolution of the human
- 52:33brain such that we
- 52:35became self-aware creatures that we discovered these mushrooms on the African
- 52:41savannah when it was,
- 52:42um, more of a wet land, I guess. Um, and that upon eating them, we discovered
- 52:49something that ended up
- 52:51having us be more inclined to keep eating them. And we ate them for a period of time
- 52:55and they had some
- 52:55sort of effect on our brain, which then helped forward our evolution into the
- 53:00self-aware creatures
- 53:00that we are now. Again, contentious, but if we're going to talk about the history
- 53:04of psilocybin, it's
- 53:05important to point out that this is a theory that many people think is
- 53:10reasonably ish plausible.
- 53:11Now, in terms of, uh, in terms of its present use, um, and where it's at in
- 53:23clinical and research,
- 53:25uh, we have found that psilocybin can, uh, produce classically defined mystical
- 53:32experiences,
- 53:32which is effectively to say that we, if we give a sufficient enough dose of
- 53:35psilocybin to someone,
- 53:36there's a very high likelihood that they will have an experience that just when
- 53:41described fits enough
- 53:42of the qualities of what we would call a mystical experience as defined by
- 53:46classical mystical text to
- 53:48say that that was a mystical experience. Um, which is to say it matches the
- 53:53characteristics of,
- 53:54of these experiences as it was represented in religious and mystical texts. Um, we
- 54:01know that
- 54:01people generally, uh, from the research rate their psilocybin experiences as in
- 54:06the top five most
- 54:07meaningful experiences of their life next to the death of a parent or, um, the, uh,
- 54:13birth of their first child.
- 54:16We know that, uh, in clinical practice, there's some evidence for it in a
- 54:23psilocybin therapy session.
- 54:24You could see a picture there from, um, I think it's John Hopkins, uh, of a
- 54:28psilocybin therapy session
- 54:30that they're able to seemingly have profoundly positive, uh, therapeutic
- 54:36effects for treating
- 54:37things like depression, end of life distress, which is effectively when we're
- 54:42distressed, having anxiety and depression and fear and panic and all the rest for
- 54:46the fact that we're
- 54:46dying, um, for anorexia, for, uh, smoking cessation for obsessive compulsive
- 54:52disorder.
- 54:53Um, but we have some other interesting things, which is that
- 54:56part of the consequences of consuming psilocybin other psychedelics are in this
- 55:02camp, but psilocybin
- 55:03in particular for this example is that it has an effect on effectively the brain's
- 55:10capacity to alter
- 55:13its own, um, basically to alter its connectivity. Well, we saw the
- 55:19connectivity, you know, that picture
- 55:21of like rapid, more connectivity under the influence, but it also increases what is
- 55:25called neuroplasticity,
- 55:26the brain's ability to change itself as well as provides, uh, an uptick in this
- 55:32sort of compounds
- 55:33or the proteins, the neural proteins necessary to make changes in how the brain
- 55:38is kind of laid out
- 55:39would be like the functional connectivity, perhaps even the structural connectivity,
- 55:43changing the physical
- 55:44connections. Why that's interesting is because, well, that's likely involved in
- 55:51its therapeutic effects,
- 55:52but it also has shown to might be involved with part of me. It might be involved with
- 55:57why it is that psilocybin seems to have such a profound effect on things like, um,
- 56:02traumatic brain
- 56:03injury. When we have a traumatic brain injury, our brain is damaged. You might
- 56:08not know it from this
- 56:09talk, but I know well what a traumatic brain injury is like. I've had,
- 56:13unfortunately, a couple of them.
- 56:14And the last one I had has really negatively impacted my life in a very
- 56:19significant way. Um,
- 56:20and I am not the same person, but anyway, so after a traumatic brain injury, your
- 56:26brain doesn't
- 56:26get back the damage. Like it doesn't pardon that sound. Um, it doesn't repair
- 56:32the damaged neurons.
- 56:33What it does is it remaps same with a stroke. We don't, when we rehabilitate
- 56:39from a stroke, we don't
- 56:40sort of heal the damaged neurons. They're gone forever for the most part, as far as
- 56:45we know,
- 56:46what we do is we change the structure of the brain such that it can start to adapt
- 56:52and compensate for
- 56:53the lost neurons to regain function. So for example, if I had a particular pathway
- 56:59that allowed me to speak
- 57:00eloquently and poetically, and that got sheared off and those neurons damaged
- 57:06either through the direct
- 57:07impact or through the secondary injury of ongoing neural inflammation of a traumatic
- 57:12brain injury
- 57:12that I would never be able to get that back, but I could relearn it such that,
- 57:20um, new pathways could
- 57:21come in to help approximate something akin to it. So this is one of the reasons why
- 57:26we're seeing psilocybin
- 57:27for traumatic brain injury. Also interesting. And I don't have a lot of
- 57:32details on that, but I do have
- 57:33a podcast about it, which I'll link here, um, with Bob Wold is that, um, psilocybin
- 57:39along with LSD
- 57:40also seems to help interrupt or prevent what's called a, um, cluster headache or
- 57:48some call suicide
- 57:49headaches. Cause they're so bad. People like would rather be dead or literally try
- 57:54to knock themselves
- 57:55unconscious just so they don't have to experience the pain and seemingly nothing
- 57:58works to make this
- 58:00not happen except psychedelics. It's crazy. Um, and incredible. I'll leave a
- 58:06link to that. So if you
- 58:07want to follow up more, but they seem to help with treating cluster headaches and
- 58:10also quite interestingly
- 58:11and uniquely psilocybin is that it seems to increase nature connection by this. I
- 58:17mean that it increases our, um,
- 58:21our sense of being connected with nature, our sense of feeling like we are a part of
- 58:27nature and nature
- 58:28is a part of us, how we experience being in nature, what our perspectives are
- 58:32towards how nature should
- 58:33be treated. It has a significant impact in that, that seems to be unique amongst all
- 58:38the psychedelics,
- 58:39psilocybin. Um, and as that some people are starting to suggest that it might be a
- 58:44potential, um,
- 58:46uh, climate change intervention at the individual level. Uh, if we go back
- 58:51towards another podcast,
- 58:53I did with a man named John seed, he talks about deep ecology. I've also had someone
- 58:57else on the
- 58:58podcast, sky otter talking about deep ecology. The idea is that instead of
- 59:02trying to change the way
- 59:04we're conducting ourselves with the natural world, with the environment at the
- 59:08political level, at the
- 59:09top down sort of like legislation into individual level to sort of bring it from
- 59:14the individual level
- 59:15up by not just changing, by basically changing how we identify and relate with
- 59:22nature, not by changing
- 59:23just our behaviors, but our, our deep identifications with the natural world.
- 59:27Um, psilocybin seems to help
- 59:30do that. So, wow, we are 51 minutes in guys, uh, and gals and others. Um, and we
- 59:38are only at number one
- 59:40of like five. So, wow. I might need to take another break to re up this coffee,
- 59:49but let's move on to the
- 59:53next one. The next one we've got is DMT and N dimethyltryptamine. So earlier we
- 59:59described psilocybin
- 1:00:00has dimethyltryptamine in it. Uh, well, another way to say that is that the base
- 1:00:07structure of psilocybin
- 1:00:09is a sort of variation on a theme of DMT. So psilocybin, psilocin are kind of like
- 1:00:15variations of DMT. DMT
- 1:00:19also is a tryptamine and is one of the most simple tryptamines being structurally
- 1:00:24extremely similar to
- 1:00:25serotonin, um, nearly identical, uh, as you can see here. Okay. So something that
- 1:00:34is okay. Well,
- 1:00:35hold on. I'm, I'm getting a little flush cause I'm, I'm getting excited to talk
- 1:00:37about this one.
- 1:00:38DMT is a tryptamine alkaloid. It is a classical psychedelics predominantly
- 1:00:44affecting the 5-HT2A
- 1:00:46receptor, but it also affects a bunch of other receptors. 1A, 1B, 1D, 1E, 2B, 2C,
- 1:00:53and so on.
- 1:00:53It also affects the sigma one receptor and adrenergic receptors. I don't entirely
- 1:00:59understand
- 1:01:00what all of that means, but it will be relevant in a second when we'll talk about
- 1:01:03their, um, DMT's, um,
- 1:01:08potential therapeutic effects. DMT is naturally present in the, or sorry, it is
- 1:01:14rampant in the
- 1:01:14natural world. I believe it was Dennis McKenna, a famous, um, ethnobotanist who
- 1:01:19said something to
- 1:01:20the effect of, it would be easier to identify all the plants that don't have
- 1:01:24DMT than all the ones that
- 1:01:25do because it was so rampant in the world. There's also some evidence to suggest that
- 1:01:31is three,
- 1:01:31theoretically present in the human brain and might have some role in certain
- 1:01:35aspects of our experience.
- 1:01:37Although I, I, that is quite contentious. I know that it is generally strongly
- 1:01:43believed in the
- 1:01:43underground as being the case, but scientifically jury is out on that. Um,
- 1:01:50what it is though,
- 1:01:51is it's incredibly potent. So what DMT does is incredibly powerful and potent. It
- 1:01:57is near
- 1:01:58instantaneous alterations of consciousness that at a, what's called a, uh,
- 1:02:03breakthrough dose,
- 1:02:04which means you get fully into the experience can take you into such a
- 1:02:10profound alteration of
- 1:02:12perception that it, we experience ourselves as being in a completely
- 1:02:17different reality that operates
- 1:02:18on sort of time and sort of dimensional physics that are almost contrary to, um,
- 1:02:28normal states of
- 1:02:29consciousness to what we normally experience as reality. It is, uh,
- 1:02:34generally, uh, populated, um,
- 1:02:36by, or it's, it generally includes those incredibly complex geometric imagery. If
- 1:02:43you're watching this on
- 1:02:44video, you see, I have a painting here or drawing from Salvia droid, um, who I
- 1:02:49believe to be Terrence
- 1:02:50McKenna, Dennis McKenna's brother, a famous sort of like poet, author, uh,
- 1:02:56public speaker who talked a lot
- 1:02:57about psychedelics and the sort of this visual representation is like pretty
- 1:03:03close, uh, to what it
- 1:03:05feels like to smoke DMT. And we go into these impossible spaces and yet we're gone
- 1:03:12and back sometimes within
- 1:03:13five or six minutes. Um, that can be extended. I don't know if I talk about
- 1:03:18extended state DMT,
- 1:03:18but we'll get in if I do great. And if not, I'll leave a cue somewhere for a
- 1:03:24guest that I had talking
- 1:03:25about extended state DMT. Um, but we go to these incredible places that at times
- 1:03:30where we're in,
- 1:03:30it can feel like we're there for hours or lifetimes. And yet we're actually gone for
- 1:03:35five or 10 minutes.
- 1:03:36So it is, it has notably intense perceptual distortions, incredibly
- 1:03:40powerful, incredibly
- 1:03:41potent. We're talking like 40 to 50 milligrams of this thing to go into a
- 1:03:45completely different
- 1:03:46dimension of reality. And yet we're back within a few minutes. This is what I think
- 1:03:51back in the
- 1:03:51sixties, they used to call it the businessman's trip, because you could have
- 1:03:54a full psychedelic
- 1:03:55experience on your lunch break. Um, now something or another one, psychedelic
- 1:04:00bungee jumping, terrible
- 1:04:02term, great term. Um, something else that's interesting about DMT and it is
- 1:04:07present with
- 1:04:08psilocybin to a lesser degree is that one of the defining features, it's not
- 1:04:13universally present,
- 1:04:14but it's like pretty close is that we experience encounters with entities by
- 1:04:22this. I mean, we
- 1:04:23enter into this experience. We're going to a totally different reality. And while
- 1:04:28we're there,
- 1:04:29it appears as though that reality we're in is populated. It is populated by other
- 1:04:34intelligent
- 1:04:35beings that are separate from us. At least seemingly they are separate from us and we
- 1:04:40interact with them.
- 1:04:41They interact with us. They try to communicate with us. We try what is like,
- 1:04:46uh, we try as Terence McKenna
- 1:04:49said to not give into astonishment. Um, and, uh, it's incredibly interesting and
- 1:04:58odd when we talk,
- 1:04:59when we think about, you know, philosophically the study of these
- 1:05:03psychedelics, you know, like,
- 1:05:04what is that? Are we interacting with other entities? Like, are these aliens? Is
- 1:05:08this how the aliens are
- 1:05:09talking to us? Don't worry about that statement. I, I said it somewhat, you
- 1:05:13know, like playfully,
- 1:05:14I am also genuinely not sure, but nonetheless encounters with entities is
- 1:05:20quite common.
- 1:05:21Now over the last, I don't know, 10 years, I think, um, uh, free basing DMT, uh, has
- 1:05:29gotten much more
- 1:05:30sort of present, like the sort of, which is to take it directly because you have to
- 1:05:35take it either free,
- 1:05:37rebase it, which is to smoke it or inject it intravenously in order to have an
- 1:05:42experience with DMT.
- 1:05:43We have molecules in our body. We have enzymes in our body called monoamine
- 1:05:47oxidase, uh, enzymes that
- 1:05:50will break down the DMT so fast. That's why it's so short and so intense that if
- 1:05:56we just eat it,
- 1:05:58or we even like intramuscularly inject it, we're just not going to get there.
- 1:06:02Nothing's going to happen
- 1:06:03because it'll never reach the brain in sufficient enough levels to take us
- 1:06:06anywhere because the body
- 1:06:07breaks it down really quickly. Uh, which is why free basing and smoking it or
- 1:06:11injecting it is the only
- 1:06:12way to get this full experience of intravenous injector, which I don't
- 1:06:16recommend. I don't
- 1:06:17recommend any psychedelics. I'm just telling you about these things guys. Like
- 1:06:20don't, don't think
- 1:06:21that I'm recommending any of it. Should have put that at the beginning. Maybe I'll
- 1:06:26quickly cut this
- 1:06:27in at the beginning, not recommending psychedelics here guys, gals, others. Um,
- 1:06:33it wasn't particularly popular from what I understand in the sixties when
- 1:06:40psychedelics were
- 1:06:40kind of like wild, wild and out, you know, prior to the criminalization, but it has
- 1:06:46gotten more popular
- 1:06:46in the last 10 or 15 years. And I think a lot of that has to do with the underground
- 1:06:50culture, underground
- 1:06:51discussions and the descriptions of how this crazy experience, um, and what it
- 1:06:56seems to offer.
- 1:06:57Um, and also with the ongoing sort of development of technologies like vape
- 1:07:02pens, where you can buy
- 1:07:03DMT and vape pens now making it much more accessible. Um, but arguably more people
- 1:07:10know about DMT, not because
- 1:07:12of the free base DMT experiences, but because of, um, ayahuasca, uh, because of
- 1:07:19the global phenomenon.
- 1:07:21Of ayahuasca. Now,
- 1:07:23the reason I say that it's because of ayahuasca is because ayahuasca DMT is
- 1:07:30present in ayahuasca.
- 1:07:31It is the DMT that makes this incredible experience. Um, well, the visual aspects
- 1:07:37of the ayahuasca
- 1:07:37experience. So first off, what is ayahuasca? So ayahuasca is a traditional
- 1:07:41sacred beverage used
- 1:07:42by various indigenous cultures in the Amazon rainforest for at least centuries.
- 1:07:46It tastes something between,
- 1:07:49uh, uh, uh, just like raw plant matter, sewage and lightning, um, depending,
- 1:07:59depending on the brew.
- 1:08:01Um, and it has, it is used in these sacred ceremonies. It is a combination of a vine
- 1:08:08called
- 1:08:08banisteriopsis cappy or the ayahuasca vine and a leaf. Generally, this is the basic
- 1:08:13two ingredients,
- 1:08:14a leaf called Cicotria viridis or tracruna. And the leaf contains DMT. The
- 1:08:21vine contains
- 1:08:22inhibitors to monoamine oxidase, meaning that when we drink it, we can have it
- 1:08:26blocks the enzymes that
- 1:08:28would prevent DMT from being orally active, which makes it so that instead of
- 1:08:32this being something that
- 1:08:33you smoke in order to be in another space for about five to 10 minutes, it is
- 1:08:38something you can drink.
- 1:08:39And it takes you into this space for five ish hours. Um, generally, and I think
- 1:08:47rightfully,
- 1:08:48uh, ayahuasca is used in sort of heavily structured ceremonial settings, uh, as a
- 1:08:54religious drink,
- 1:08:55although it is increasingly being sort of used and promoted as a therapeutic
- 1:09:00beverage as well.
- 1:09:01Um, so this has exploded around the world. There are, um, people drinking ayahuasca
- 1:09:10in traditional,
- 1:09:11nontraditional, and mixed religious context from California to England, to
- 1:09:15China, and even mixed
- 1:09:17groups of Muslim, Jewish, and Christians drinking together in the West Bank. I did
- 1:09:21a whole podcast with,
- 1:09:22um, Anton, Antoine Saka and Lior Roseman talking about the incredible healings that
- 1:09:28are happening.
- 1:09:28Um, this was well before the current sort of
- 1:09:32war undergoing, uh, in that area right now. Um, but it has exploded all around
- 1:09:40the world. There are even
- 1:09:41three major religions, uh, or at least two major religions that utilize ayahuasca as
- 1:09:47their sacrament,
- 1:09:48the UDV and the Santo Daimi, both of which have international representation and the
- 1:09:54research,
- 1:09:54both anecdotal, um, and, uh, sort of clinical scientific shows that it has
- 1:10:01incredible antidepressant
- 1:10:03effects and even longstanding positive effects on neurological health. So the
- 1:10:08allure of ayahuasca
- 1:10:10and the positive benefits it offers has resulted in it spreading all over the
- 1:10:15world for good,
- 1:10:16perhaps also for ill. Um, I'll let you decide. And, uh, arguably that's how most
- 1:10:22people know about DMT.
- 1:10:24If they know that DMT is in it. So in research, what we know about DMT, uh,
- 1:10:31presently is it's being,
- 1:10:32uh, it's rapid onset and short duration makes it ideal for controlled research
- 1:10:38settings, um,
- 1:10:39and potentially for therapeutic use with psilocybin. We're looking at, you know,
- 1:10:43five ish hours
- 1:10:45and you really have to be holding that person for five ish hours. We, you know,
- 1:10:50with LSD,
- 1:10:50you're looking at 10 hours. There's a lot of time that goes into that. Now, arguably
- 1:10:54there's a lot
- 1:10:55more work that can be done in 10 hours than in five minutes. But, um, the fact
- 1:11:01that DMT is only five,
- 1:11:02a five, 10 minute experience makes it ideal for therapeutic use. If we're trying
- 1:11:07to minimize the
- 1:11:08amount of time that we have to be investing in that person because
- 1:11:12professional service costs money.
- 1:11:14Um, and also in research settings, we don't, you don't, again, it costs less to
- 1:11:19do this research.
- 1:11:20Um, now also what's very interesting is that of course, DMT is quite unique. The
- 1:11:26effects of DMT on
- 1:11:26the brain and how it takes us into altered states of consciousness and what it's
- 1:11:31showing us about the
- 1:11:32neurological correlates of consciousness is incredibly interesting and is presently
- 1:11:36being researched,
- 1:11:37especially by, um, the main researcher that comes to mind is Chris Timmerman.
- 1:11:42I've had him on the show
- 1:11:43as well, do a little link. Um, but I haven't had him on the show in a while and
- 1:11:48he is, his,
- 1:11:48his work is just expanding. Um, and it's incredible to watch. Uh, so other research
- 1:11:54is that we have some
- 1:11:55research right now suggesting that it could be effective for depression. Um, and
- 1:12:00then also neurological
- 1:12:01rehabilitation, uh, particularly after stroke or cardiac arrest. And this is
- 1:12:07because it has an
- 1:12:09anti-inflammatory neuroprotective and neuroplastic effect. So what that means is
- 1:12:13that it reduces
- 1:12:14inflammation in the brain, which inflammation and oxidative stress in the
- 1:12:18brain, which causes
- 1:12:18neuronal death is a significant contributor to what earlier described as
- 1:12:23secondary injury from
- 1:12:25concussion, but can also be present after cardiac arrest and stroke, which can cause
- 1:12:30at the very
- 1:12:31least the minimize minimizing of rehabilitation's potential, but at worst
- 1:12:36further damage and neuronal
- 1:12:38death. When we can reduce that inflammation, we can reduce that. We can
- 1:12:43increase the likelihood of
- 1:12:44rehabilitation from a neuroprotective standpoint. We're talking about protecting
- 1:12:48from oxidative damage,
- 1:12:50protecting for further stresses on the brain. And when I say neuroplastic, I'm
- 1:12:53talking about the ability
- 1:12:54to remap new networks to compensate for the damage or loss neurons. Seemingly part
- 1:13:00of why DMT can do that
- 1:13:02is uniquely because of its effect on Sigma one receptors. I'll leave you to research
- 1:13:07that if you are more
- 1:13:08interested, um, because I don't entirely know much past what I just said there, uh,
- 1:13:13with respect to Sigma one.
- 1:13:16And here's one of the editorial breaks we're going to do. Uh, and I'll be right
- 1:13:20back.
- 1:13:20Okay. So the next one we're going to talk about is MDMA. MDMA again, uh, or not
- 1:13:29again, MDMA is not
- 1:13:31in the splitter category. We're including MDMA in the lumper category as a
- 1:13:37psychedelic. MDMA stands for
- 1:13:393,4-methylene-dioxymethamphetamine. And yes, in fact, it is a methamphetamine
- 1:13:43molecule, which we'll talk
- 1:13:44about in a second. Structurally, it's very different, uh, extremely different from
- 1:13:49LSD or sorry, excuse me,
- 1:13:50psilocybin or DMT, totally different molecular structure, totally different
- 1:13:55effects. Rather
- 1:13:56than an indole ring, its core is a benzene ring with a two carbon chain and amino
- 1:14:01group. Um, it is, uh,
- 1:14:04what's called a phenethylamine molecule where psilocybin DMT, tryptamine
- 1:14:10alkaloids, um, MDMA,
- 1:14:12um, phenethylamine. The molecular structure of this molecule, um, allows for
- 1:14:19a lot of potential
- 1:14:20alterations, um, which is incredibly interesting. And I mean this, uh, the
- 1:14:24phenethylamine molecule,
- 1:14:26uh, uh, for example, mescaline, which is another phenethylamine psychedelic, uh,
- 1:14:32which is not
- 1:14:33something we're talking about today, but has an incredible interesting history.
- 1:14:37How, um, Sasha
- 1:14:38Shogun, Alexander Shogun, famous, um, chemist managed to create over 200
- 1:14:42different psychedelic molecules
- 1:14:44from just subtle variations of mescaline alone. Not sure that has anything to do
- 1:14:50necessarily with MDMA,
- 1:14:51but it's an interesting point. Uh, so MDMA is a phenethylamine and other
- 1:14:56phenethylamines that you
- 1:14:57might know of include the endogenous cancer colamine, such as dopamine and
- 1:15:01norepinephrine,
- 1:15:02but it also includes drugs like amphetamine, which are, is obviously
- 1:15:06related to methamphetamine,
- 1:15:08uh, methylphenidate or Ritalin, if you know that brand name, propropion or
- 1:15:13Welbutrin,
- 1:15:15pseudoephedrine, um, as well as, like I said, mescaline and it's many analogues.
- 1:15:20Uh, so MDMA is not considered generally a psychedelic outside of people just saying
- 1:15:28psychedelic medicine, psychedelic research, psilocybin, MDMA. Um, generally
- 1:15:33it's called, um,
- 1:15:35tends to be referred to as an intactogen. It is one of a small, but growing set of
- 1:15:40molecules
- 1:15:40that would qualify as intactogens such as MDMA. But then you also have, I believe
- 1:15:45five ATB, uh,
- 1:15:48four MMC, three MMC, um, and M E A I, for example, uh, there's just like a lot of
- 1:15:55different variations
- 1:15:56of these things that we call intactogens. Intactogen intactogens comes from the
- 1:16:01and meaning within tactus meaning touch and gen as in generating. So this term
- 1:16:08intactogen coined by
- 1:16:10researcher, David Nichols in 1986, effectively means generating the
- 1:16:15experience of touching with it.
- 1:16:16It is to sort of like increase our sense of being in touch with ourselves, with
- 1:16:21each other,
- 1:16:21generating a sense of being in touch. Um, MDMA does target serotonin similar, you
- 1:16:29know, uh,
- 1:16:30both DMT and, uh, psilocybin target serotonin, but in a totally different way,
- 1:16:35as opposed to generating, um, impacting with the five HD two a receptor. Oh my
- 1:16:41goodness. There's a
- 1:16:42giant, such distraction. It's a giant, uh, mosquito in my room that hopefully does
- 1:16:48not bite me while I'm
- 1:16:50focusing. Hopefully it doesn't get in on the skin while I'm engaged in a task
- 1:16:55positive network on a
- 1:16:56different topic or a different, um, different focus. Yes. Okay. So instead of,
- 1:17:02uh, interacting with the
- 1:17:03serotonin five HD two B to five HD two a receptor, excuse me. Um, MDMA targets the
- 1:17:14cert gate. So the
- 1:17:15cert gate is basically, um, the part. Okay. So in a neuron, we have, uh, the
- 1:17:23axon and we have the synapse,
- 1:17:25and we have this sort of like, I hope this is right. You have to pardon me, but
- 1:17:29nonetheless,
- 1:17:29we have this little pocket. If you imagine, if you're just listening to this,
- 1:17:33I've got my one hand
- 1:17:34open, like a C and my other hand, like a fist. And the C sort of reaches over the
- 1:17:38fist and the gap
- 1:17:39between the fist and the open hand, the C that's called the synaptic clef, um,
- 1:17:48molecules, neurotransmitters,
- 1:17:50neurons, neuromodulators, molecules come out into the synaptic cleft through these
- 1:17:54little vesicles.
- 1:17:55And when they're in there, they're able to sort of bind into little sites that
- 1:18:01influences the firing
- 1:18:03of that neuron. Um, they get released into the synaptic cleft and then there are, um,
- 1:18:09aspects of
- 1:18:10the neuron that then sweeps it up. It cleans, cleans them out of the cleft, um,
- 1:18:15so that they can get what's
- 1:18:17called like reuptaken, brought back in towards the receptacle to be reused again.
- 1:18:22And the cert gate
- 1:18:22is part of that process. It's part of like cleaning up the excess serotonin so that
- 1:18:27there's not too much
- 1:18:28in the cleft and so that it could be reused. MDMA reverses that function. And
- 1:18:35instead of cleaning up
- 1:18:36the serotonin, it creates, uh, it basically pushes it out, just squeezes all
- 1:18:42that serotonin out of these
- 1:18:44little vesicles and makes it so that it can't be brought back in. So what that
- 1:18:48effectively results
- 1:18:49in is a massive increase in serotonin in the synaptic cleft, meaning that we
- 1:18:55basically get high
- 1:18:55on massive serotonin simultaneously. Um, as a methamphetamine molecule, they're
- 1:19:02also similar
- 1:19:03thing is happening with both dopamine and norepinephrine. So with dopamine being
- 1:19:07kind of like
- 1:19:08the molecule of more, like the molecule of craving, of seeking, of like desiring, of
- 1:19:14like getting into a
- 1:19:15thing of like wanting to basically seek and find. And, uh, norepinephrine is the
- 1:19:19molecule of go and
- 1:19:21serotonin maybe as the, I don't know how to describe that, but you have this wash
- 1:19:26of these three
- 1:19:27predominant neurotransmitters, neuromodulators in high amplitude, um, as
- 1:19:33a consequence of
- 1:19:34method or, um, MDMA's activity, um, where what makes MDMA unique to methamphetamine
- 1:19:41is the presence
- 1:19:42of these massive heights of serotonin. So, um, what does MDMA do?
- 1:19:51And I'm going to read a little bit more of my notes here in this one. So you have to
- 1:19:54pardon me,
- 1:19:54but MDMA has a tendency to make us feel good, like really good, really, really
- 1:20:01good. And not just
- 1:20:03our emotional feelings, but our tactical sensations, touch can be dramatically
- 1:20:07heightened to the point
- 1:20:08where everything we touch feels really good. And we just want more of that touch.
- 1:20:13This can include
- 1:20:14physical touching, such as like, if you've ever met someone that's high on, I should,
- 1:20:20clarify, let's go back a bit and I'm going to talk about this. So MDMA also is the
- 1:20:26main ingredient,
- 1:20:27primary ingredient of what's called ecstasy. Ecstasy is usually a blend of
- 1:20:32different molecules,
- 1:20:33which should theoretically have MDMA in it, but not always. And then also another
- 1:20:37stimulant and maybe
- 1:20:38some other stuff. And they're usually sold in press tablets. The bottom right photo
- 1:20:43here, you see
- 1:20:44from the DEA, they have a picture of some ecstasy tablets, often used in party
- 1:20:49So coming back to that, if you've ever met someone at a party, for example, it was
- 1:20:56high on MDMA or high
- 1:20:57on ecstasy, you might've noticed them like really wanting to give you a hug. There's
- 1:21:02like a strong
- 1:21:02desire to like be in physical contact because it feels so good or to be touching
- 1:21:08soft things,
- 1:21:10soft pillows or blankets or cuddling stuffies or whatever it is.
- 1:21:16So we have this increased, sorry, we have the increase of tactical sensations
- 1:21:24feeling very good,
- 1:21:25which includes physical touching, but it can also include non-physical touching as
- 1:21:30in like touching
- 1:21:31the beauty of a plant with your vision or touching the emotional tone of the music
- 1:21:35that you're listening.
- 1:21:36So we're not just like, Ooh, that feels really good on my skin. Like the, that
- 1:21:41blanket feels really good
- 1:21:41on my skin, but that music feels really good on my soul. Like it just like
- 1:21:46everything, the tactical
- 1:21:48feelings are all just sort of generated heightened and it has a particular quality
- 1:21:54to it. It has what,
- 1:21:55you know, I think is fairly well described as a kind of love energy where we find
- 1:22:01ourselves deeply
- 1:22:02loving whatever and whomever it is that we are engaged in. We love that music. We
- 1:22:06just love this
- 1:22:07pillow. We just love ourselves. And we just love even aspects of ourselves that
- 1:22:12normally we dislike.
- 1:22:14Like I look in the mirror and normally I have issues with my body, but on MDMA, I
- 1:22:19look in the mirror and I
- 1:22:20say, I'm just, I just love you so much. I love my body. I'm so sorry that I've
- 1:22:24always been hard on you.
- 1:22:27We are able to just like be in deep love with things, even to the point of a sort
- 1:22:33of like
- 1:22:33surrendering to just being in love and loved by the universe to being sort of
- 1:22:40washed in just like
- 1:22:42love with a capital L permeating our entire being and generating incredible,
- 1:22:47uh, sense of gratitude
- 1:22:48for being alive. These are all kind of possible with MDMA. Um, and because it's
- 1:22:54not just this deeply
- 1:22:55loving energy, but because we have this high impulses, this sort of like push of
- 1:23:02the norepinephrine
- 1:23:03and this like desire of the dopamine, it's not just that we feel increased love, but
- 1:23:09we actively
- 1:23:10love, we want to love. We want to sort of like, if it's a person, we want to
- 1:23:14actively love that person.
- 1:23:15We want to listen because we want them to feel how much we love them and are
- 1:23:19listening. And we want to
- 1:23:20tell them how much we love them. We want to share that, which is where like the, I
- 1:23:23really want to give
- 1:23:24you a hug energy comes from. Um, and this is not necessarily sexual. There can be
- 1:23:30very incredible
- 1:23:31sexual sexuality feelings. Um, but generally it's very sensual and
- 1:23:38oftentimes, uh, even when they are
- 1:23:40sexual, especially men or sorry, well males, um, can't really do anything about
- 1:23:47it. Uh, just because
- 1:23:48things won't, uh, uh, uh, fire at attention necessarily. Um, so what ends up
- 1:23:55happening
- 1:23:55generally is this incredibly close sensual state of what some people call being
- 1:24:01something like in the
- 1:24:01post orgasmic state, um, with no explicit desire or capacity for sexual engagement.
- 1:24:07Um, and, uh,
- 1:24:12this is something that we could share with another person or anything that we're
- 1:24:17engaging it with.
- 1:24:17Sorry. I'm getting, got a little bit, I'm going on for a long time. I'm running, I'm
- 1:24:21running out of
- 1:24:21steam here guys. Um, this loving energy, this desire to move in desire to have
- 1:24:29people come into us
- 1:24:30emotionally, um, is also related to our boundaries. MDMA produces an increase in
- 1:24:38our perceived sense of
- 1:24:39safety and a decrease in our perceived sense of danger. I want to clarify this
- 1:24:44for a second because
- 1:24:45it's often misunderstood that safety and danger are related in, in like linear ways
- 1:24:53that the, that the
- 1:24:55increased presence of danger reduces our sense of safety and the increased sense of
- 1:25:00safety is relative
- 1:25:00to a decreased presence of danger. That's not true. They're separate things. A sense
- 1:25:06of safety is how we
- 1:25:07feel right. And danger is about what's actually present. What is actually a
- 1:25:13threat, perceived
- 1:25:14threat or otherwise. So for example, I could be on the highway. The highway is
- 1:25:20very dangerous,
- 1:25:20right? If I'm going, you know, a hundred kilometers an hour and there are cars all
- 1:25:25around me going
- 1:25:25faster than that. And these things are all little death machines. One wrong move can
- 1:25:30completely end the
- 1:25:30lives of like, you know, at least one, if not many, many people. It's incredibly
- 1:25:37dangerous to drive on
- 1:25:37the highway, but most people also feel really safe on the highway. And
- 1:25:42simultaneously you could be in a,
- 1:25:44people could be in a scenario where they go into a room full of people and everyone
- 1:25:48there, none,
- 1:25:49nobody there is a danger to them. Not in the slightest, not a single person in any
- 1:25:53way is a danger to them,
- 1:25:54But they feel incredibly unsafe, right? So this is what I mean by there's a, it's not
- 1:26:00so linearly tied
- 1:26:01between safety and danger, but MDMA can increase our sense of danger, or sorry,
- 1:26:05increase our sense of
- 1:26:06safety and decrease our perceived sense of danger. So things that we would normally
- 1:26:10perceive as dangerous,
- 1:26:11we don't feel are as dangerous, and we have an increased sense of safety. Now,
- 1:26:18what that allows for is it makes
- 1:26:21it so that there's a decrease in our boundaries. Normally we would hold certain
- 1:26:25boundaries because
- 1:26:26of how our sense of safety or a sense of danger, especially emotionally, and that
- 1:26:31when we're on
- 1:26:31MDMA, those boundaries can dissolve. And we're basically able to be and feel closer
- 1:26:38with others
- 1:26:40and with ourselves than we would normally allow ourselves to be. That we would, in
- 1:26:46general,
- 1:26:47maybe we're more closed off, and we're going to be more open with other people.
- 1:26:51Now, I want to bring in that. Okay, actually, we're going to talk about this
- 1:27:00in a second with respect
- 1:27:01to how all of this plays out in its role in therapy. This closeness, this loving
- 1:27:07energy and sharing impulse
- 1:27:09with others is an important part of MDMA, as it's often considered a relational
- 1:27:15medicine. Whereas
- 1:27:17compounds like psilocybin can be relational, they can include interacting
- 1:27:22with others or being in
- 1:27:23relational dynamic with the universe of the plants or so on, they're often very
- 1:27:29internal experiences.
- 1:27:32And there are times during the experience where it's incredibly difficult to
- 1:27:36communicate at all,
- 1:27:37like even to formulate what we're experiencing in words, let alone share it
- 1:27:41and communicate it with
- 1:27:42another person. MDMA can be an internal experience, but it thrives under
- 1:27:47conditions where we can talk,
- 1:27:48and we want to talk, and we want to share, and we want to engage with other beings.
- 1:27:53Be that person, a therapist, or other people, or, pardon me, in the instance of
- 1:27:59wanting to have
- 1:28:00like a deeply relational experience with various parts of ourselves.
- 1:28:04Now, therapeutically, we have what's called MDMA-assisted psychotherapy. It
- 1:28:13almost got legalized
- 1:28:15in the US recently, but there was some issues with the research and sort of
- 1:28:21methodology that led
- 1:28:21the FDA not to approve it. That's a bigger topic for now anyways. But what we do know
- 1:28:31is that it is
- 1:28:32historically has been, was used before it was criminalized, and we'll talk about
- 1:28:37that in a bit,
- 1:28:37in couples therapy. Now, the reason why it was so good in couples counseling is
- 1:28:45because
- 1:28:47the boundaries are down. And what we normally hold ourselves back from
- 1:28:53in ourselves and seeing in the other or seeing in our own behavior.
- 1:28:56Sorry, I'm getting, I'm half reading my notes, half talking. I'm getting quite
- 1:29:01tired now. My brain is
- 1:29:02starting to, it's 11am and I'm sundowning.
- 1:29:10When we are in, when we're under the effects of MDMA, if you can imagine being
- 1:29:16in a relationship,
- 1:29:17maybe you've been in this before, either intentionally or unintentionally, be it by
- 1:29:23circumstance or history or whatever it is, we can put up walls with each other. And
- 1:29:29all relationships
- 1:29:30experience conflict, right? And sometimes conflicts can be resolved. Always
- 1:29:35conflicts can be very
- 1:29:37regenerative. They can deepen our love and our intimacy and our trust with each other
- 1:29:40if we
- 1:29:40navigate them well. But if they don't get navigated well, they can start to put up
- 1:29:43these walls and they
- 1:29:44can become almost constant or in retractable. We get stuck in these
- 1:29:50conflicts. Our walls are so
- 1:29:51hard up against the other person that we can't even talk, let alone reconnect with
- 1:29:55why we even care
- 1:29:56about being in a relationship with them. When we're under the effects of MDMA,
- 1:30:01there's this opportunity
- 1:30:03for those walls to come down and for us to really talk with each other again. Like in
- 1:30:08a couple's
- 1:30:09situation, it's an inclination not only to let that other person in, but to let
- 1:30:15ourselves see the aspects
- 1:30:16of how we were contributing to that situation that we didn't want to. And it
- 1:30:21can be done in a way that
- 1:30:22infuses that interaction with love, reminds us that we love this person, that
- 1:30:27it's our love for them that
- 1:30:29makes working this out worthwhile, while pharmacologically we're also supported in
- 1:30:34actually working it out. Not just because we're able to listen, not just because
- 1:30:39we're able to listen
- 1:30:40and receive and look at ourselves, but we're able to reveal. It increases a term
- 1:30:46I got from a group called
- 1:30:47the LSA, the Liminal Space Agency, and we're kind of a community organization
- 1:30:53here in where I live in
- 1:30:55Kitchener, Waterloo. It can increase the talk about ability of things. And if it's
- 1:30:59mentionable,
- 1:30:59it's manageable. It's a totally different terminology or different phrase, which is
- 1:31:03where we can now see
- 1:31:06its benefits in couples therapy. We're safer to open to ourselves and open
- 1:31:10ourselves to our partner.
- 1:31:11And we're able to talk about things, process things that we otherwise would
- 1:31:15have been closed
- 1:31:16up against. And all of this is infused with that love energy of MDMA. And then,
- 1:31:21and in that it's like,
- 1:31:22you want to hug them. You want to hold them. You want to love them. You want to
- 1:31:26tell them about
- 1:31:27yourselves. You want to hear about them and you want to share openly and within
- 1:31:30your love with them,
- 1:31:32while you also process what could be incredibly difficult or challenging
- 1:31:36conversations that otherwise
- 1:31:37would have been inaccessible and perhaps otherwise would have been, um,
- 1:31:41the end of the relationship. Um, now that's also one of the reasons why two
- 1:31:50points here. One,
- 1:31:51it's one of the reasons why it's probably not a good idea necessarily to have deep
- 1:31:55focused MDMA sessions
- 1:31:57with someone who you're only just recently dating, uh, or seeing, because it can give
- 1:32:02you a real distorted
- 1:32:02sense of how close and intimate you really are, which is not necessarily, uh, to the
- 1:32:07relationship's
- 1:32:08benefit. The ability to hold that kind of vulnerability and intimacy is best served
- 1:32:12by
- 1:32:12the establishment of a kind of trust between you that can only be earned
- 1:32:16through time and work.
- 1:32:18It can't, that if we flood it with too much vulnerability and intimacy too
- 1:32:23quickly,
- 1:32:23the sort of what I like to call the trust trustworthiness bridge that we build
- 1:32:28between us
- 1:32:28through exchanges of trust and trustworthiness creates a wider, deeper,
- 1:32:33stronger bridge to hold
- 1:32:34our vulnerabilities and intimacies. And if we haven't built that, when we start
- 1:32:38flooding it all in there,
- 1:32:39well, that bridge can collapse and the relationship can collapse. If we, for
- 1:32:44example, take MDMA,
- 1:32:45we can have the illusion that that bridge is really strong and deep, but it was
- 1:32:48actually bolstered by
- 1:32:49this molecule. And when that molecule is not there, eventually it's all going to
- 1:32:53collapse.
- 1:32:53Um, if we're not careful, not definitely, but it's still something to be careful
- 1:32:57about.
- 1:32:57Now with respect to MDMA in post-traumatic stress disorder, PTSD, this is where it's
- 1:33:04most of its
- 1:33:05research is now. Now, the data that I'm about to share is the data that ended up
- 1:33:11being contested.
- 1:33:12So this is real like grain of salt stuff, but it seemed as though the MDMA sessions,
- 1:33:18they were sending or giving people, which is basically, um, under the effects of
- 1:33:24MDMA,
- 1:33:24they're going through a kind of psychotherapeutic process. From what I
- 1:33:27understand, it was very closely
- 1:33:28to internal closely related to internal family systems where they were changing
- 1:33:32how they related
- 1:33:33to themselves and their past events and their, the trauma and so forth that
- 1:33:37participants who otherwise
- 1:33:39were, um, suffering from what's called, um, treatment resistant, uh, PTSD, which
- 1:33:46terrible
- 1:33:46terminology and infers that the person is resistant to treatment rather than the
- 1:33:50treatment is ineffective.
- 1:33:51Um, but these are people who tried basically everything and nothing worked.
- 1:33:57And, um,
- 1:33:5870% of those participants no longer met the PTSD criteria after two MDMA assisted
- 1:34:05therapy sessions,
- 1:34:06compared to about 32% of people in conventional therapy.
- 1:34:10So with respect to PTSD, the sense of safety that MDMA and the sense of love
- 1:34:17that can and allow us,
- 1:34:18allows us to enter into the traumatic experiences that are normally too much too
- 1:34:22soon, too fast for us to
- 1:34:24enter into. And there's a defensive response and anxiety response, a
- 1:34:28non-constructive response when we,
- 1:34:30you know, touch those traumatic experiences. And so we're able to go into
- 1:34:34that and be more receptive
- 1:34:36to ourselves, to that experience, to carrying energy flowing from ourselves or
- 1:34:41from beyond us,
- 1:34:42or, you know, to be able to work with the therapists in ways that allow us greater
- 1:34:46access to these traumatic
- 1:34:48memories such that we can process them. And again, to infuse all of that with
- 1:34:52loving energy and loving impulse,
- 1:34:54not only towards ourselves. Um, oh, but in the context of PTSD now towards ourselves
- 1:35:00in the form of, um,
- 1:35:01compassion or forgiveness, or even compassion, forgiveness to those who
- 1:35:06harmed us. And as you
- 1:35:07can imagine, that could be quite helpful in resolving trauma. Um, now with respect
- 1:35:15to the history of MDMA,
- 1:35:16um, it was first synthesized by Anton Kolisch at Merrick in 1912. It was
- 1:35:22rediscovered by chemist
- 1:35:24Alexander or Sasha Shulgin in the seventies, who I just mentioned
- 1:35:27previously, who did all those remix
- 1:35:29molecules of, uh, of mescaline and along with his wife and they helped popularize
- 1:35:36its use among couples,
- 1:35:37therapists and therapists. Um, and eventually it made its way in the party
- 1:35:42scene where it started blended,
- 1:35:44getting blended with other substances like press pill in press pills, which we call
- 1:35:49ecstasy.
- 1:35:49Um, and it actually played an incredible role in the development of rave and EDM
- 1:35:55culture in the eighties
- 1:35:56and nineties. Um, in fact, like plur, peace, love, unity, and respect. You know,
- 1:36:00if you imagine
- 1:36:01when you have sometimes hundreds more than hundreds of people all in one space, just
- 1:36:07listening to dance
- 1:36:08music and they're all on MDMA, you can imagine things go a lot better than when
- 1:36:13that's happening in
- 1:36:14everyone's on alcohol, for example. Uh, and I think that was a significant
- 1:36:19contributor to concepts
- 1:36:20like peace, love, unity, and respect, which is a really sort of central theme in
- 1:36:24rave, at least
- 1:36:25classic rave culture. Um, it was criminalized in the mid 1980s, right in
- 1:36:30the middle of a lot of
- 1:36:31very important research that was underway at the time. Okay. You might've noticed a
- 1:36:36little cut
- 1:36:37there. Um, I started to fade. I have post post brain injury. Uh, I, uh, have limited
- 1:36:46resources
- 1:36:46cognitively. So at some points I start to get confused and start to not understand
- 1:36:52what I'm
- 1:36:53saying or thinking and need to take a rest. And that is what I did. I took a
- 1:36:57rest. Uh, I drank some coffee
- 1:36:58and, um, I did actually, I was going to stop at MDMA between MDMA and ibogaine,
- 1:37:06but I'm going back,
- 1:37:07cutting away from some of the stuff that you would have just heard, um, because I
- 1:37:10was fading and
- 1:37:12poorly describing things. So near the end of talking about MDMA just then, um, I
- 1:37:17pulled up Rick Doblin.
- 1:37:18Uh, so Rick Doblin's on your screen now and, uh, he is behind the
- 1:37:23multidisciplinary association of
- 1:37:25psychedelic studies. MDMA has been incredibly important for the progression
- 1:37:31of psychedelic medicine,
- 1:37:32um, in, uh, research right now, be it psilocybin, LSD, uh, DMT, all these
- 1:37:42things. They're finding their
- 1:37:44way in, in a lot of ways because of the work that the multidisciplinary
- 1:37:48association of psychedelic
- 1:37:50studies started doing quite a long time ago with their first focus on MDMA. Now
- 1:37:56maps, uh, is not
- 1:37:58the end all be all, uh, of what's bringing the psychedelic renaissance as it is
- 1:38:03called the psychedelic
- 1:38:04resurgence, um, into the modern world, modern day. Um, but they have been a
- 1:38:09significant contributor
- 1:38:10and Rick Doblin in particular because of his advocacy work. And because he was, I
- 1:38:16believe,
- 1:38:17founder of maps maps and Rick Doblin are contentious these days. It turns out
- 1:38:24everything that has any
- 1:38:25significant impact in this world has contentious figures and organizations in
- 1:38:29the mix of it.
- 1:38:30So I'll leave you to do that research if you like, but we can definitely say that
- 1:38:34MDMA has played a very
- 1:38:36important role in the progression of psychedelic research right now and the
- 1:38:40changing landscape of
- 1:38:41how it is seen in, uh, science and in medicine, uh, psychedelics in general. And
- 1:38:47Rick Doblin has been
- 1:38:48an important contributor to that work with MDMA and through maps having been there at
- 1:38:53the, uh, criminalization
- 1:38:55and still working now to, um, forward it's legalization. So that is the end of MDMA.
- 1:39:03My tone
- 1:39:04has changed. It's because I'm still, uh, coming back from the little rest I needed
- 1:39:08to take. And I'm still
- 1:39:10waiting for this next coffee to, uh, take hold for this, uh, alkaloid to interact
- 1:39:16with my nervous system,
- 1:39:17uh, by, uh, uh, mimicking adenosine blocking, uh, selectively blocking
- 1:39:23adenosine receptors in order to,
- 1:39:25uh, trigger the experience of wakefulness.
- 1:39:28Okay. Or maybe it's like to produce, to reduce sleep pressure along with all the
- 1:39:37dopaminergic effects.
- 1:39:38You know, I'm not a, I'm not a specialist in, uh, not a specialist in caffeine. I
- 1:39:42mean,
- 1:39:42in enjoying it, certainly in describing its, uh, neuropharmacology medium mid you
- 1:39:49could say,
- 1:39:50um, before we get into the next one, which is going to be Ibogaine. Is it Ibogaine?
- 1:39:56It's ketamine.
- 1:39:56Before we get into ketamine, um, I want to take a second to thank my patrons on
- 1:40:02Patreon.
- 1:40:02Patreon is an online platform where people who care about, um, a particular creator's
- 1:40:11can contribute directly to the production of that work. Um, Patreon does take a cut
- 1:40:18such is life. Um,
- 1:40:21but it has been through Patreon predominantly that I have been able to
- 1:40:26fund this work, fund the podcast,
- 1:40:29fund my research, fund my writing, fund, you know, me doing what I hope you
- 1:40:35experience as positively
- 1:40:37contributing to the psychedelic landscape and positively contributing to people's
- 1:40:42lives on the direct basis
- 1:40:44with what I share about myself and what I share through the podcast, the things that
- 1:40:49I feature and
- 1:40:49the conversations that I'm trying to generate in the field of our minds and in
- 1:40:54the field of culture.
- 1:40:56Um, I genuinely want to leave whatever slice of the world I'm in better off
- 1:41:05because I was in it because
- 1:41:06I made an effort to do good in the world. And the only way that I understood or in
- 1:41:10the ways that I
- 1:41:10progressively learned to be goodness in this world. And with the particular skills
- 1:41:16and capacities that I
- 1:41:17have a little niche that I'm able to fit in the small little sort of pocket of life
- 1:41:22that I seem to fit
- 1:41:23within. And this is how I do that. And it's not cheap on time or energy and we're
- 1:41:31on money finances,
- 1:41:32everything costs more and more money all the time. And, uh, since my brain injury,
- 1:41:37everything costs more and more in time and cognitive resources. So through Patreon,
- 1:41:44I've been able to
- 1:41:45earn an income through doing this work. And my patrons on Patreon are people who
- 1:41:49choose to say, Hey,
- 1:41:50here's some money for doing this thing that you just give away for free to
- 1:41:54everyone. Um,
- 1:41:55here's some money to help recoup the costs of doing that. And to hopefully, you know,
- 1:42:01in time,
- 1:42:02earn enough to, you know, retire, I, I, I, I eventually will be 60 and 70. I'd like
- 1:42:09to have
- 1:42:10something there, uh, or certainly in the instances of last few years to have some
- 1:42:14kind of surplus that
- 1:42:15allows me to adapt when things go haywire, when somebody runs a red light, uh, and
- 1:42:22hits me, for
- 1:42:23example. So, um, to, to pay for the consequences of these things. So thank you
- 1:42:28patrons. Um, so much. I,
- 1:42:31I, I just deeply appreciate that you continue to have faith in me and to invest
- 1:42:35in me, even as
- 1:42:36economically things are complicated for everyone. I couldn't be more grateful. If
- 1:42:40you listening now
- 1:42:41find any kind of value in the show, please do contribute financially. Again, this
- 1:42:46takes a lot
- 1:42:46of time and resources and money to produce. Um, and if you feel like it's
- 1:42:52something you want to reliably
- 1:42:53help create and fund in this world, you could become a patron on patreon.com
- 1:42:58forward slash
- 1:42:58slash James if you Gesso as little as a couple of dollars a month would love that,
- 1:43:03uh, more if
- 1:43:03you've got more feel more is deserved. Um, or even if you just found value in this
- 1:43:09one, just leave a
- 1:43:10one-time PayPal donation, um, of any amount. I would really appreciate that.
- 1:43:15Uh, so the people, uh, on the
- 1:43:18screen whose names are on the screen here on YouTube, uh, are patrons that give
- 1:43:22significantly or give, you know,
- 1:43:24of a certain dollar amount, some of which for a long time, I mean, significance is
- 1:43:28really, you know,
- 1:43:29dependent relative to a person's financial situation. $2 can be quite significant for
- 1:43:33an individual. The people
- 1:43:34who is listed on the screen here on YouTube, um, give of a notable dollar
- 1:43:40amount, um, and some of which for a
- 1:43:42long time. So the credits there are, thank you for them to them. And, uh, yeah, links
- 1:43:47to shops,
- 1:43:48social pressure. Oh my God. Wow. That nap might not have been enough, uh, to get my
- 1:43:54brain back on,
- 1:43:55but we're here. Here's hoping, here's hoping that this, uh, this whole lecture
- 1:43:58thing doesn't fall off
- 1:43:59a cliff from here. Um, yes, uh, links to all of this will be in the description to
- 1:44:06this. And, um,
- 1:44:07thank you so much for supporting the show, supporting me and supporting this work.
- 1:44:12And, uh, let's get back into the lecture here.
- 1:44:15Oh, blessed be the lords of coffee. Um, okay. So ketamine, I am going to butcher
- 1:44:27this molecule's
- 1:44:28name. 2,2 chlorphenol, 2 methyl amino cyclohexane 1,1, uh, also known as
- 1:44:37ketamine is a dissociative
- 1:44:40anesthetic with psychedelic like effects. So ketamine is in that lumpers category.
- 1:44:46Even the
- 1:44:47experiences itself of what we would call it psychedelic like effects are, um, not,
- 1:44:53uh,
- 1:44:53particularly akin to that of say psilocybin, but it definitely fits the
- 1:44:58category of altering
- 1:45:00consciousness into other states of reality. Seemingly, um, it is neither
- 1:45:05tryptamine nor
- 1:45:06phenethylamine. It has a distinctive cyclohexane ring with a chlorinated phenyl
- 1:45:11phenyl group attached.
- 1:45:12It's actually much more closely related to PCP than cyclodyne. I think that's PCP,
- 1:45:21um, or
- 1:45:22colloquially called angel dust back in the nineties, at least. Um, and it's actually,
- 1:45:27I believe an analog PCP. Um, now, um, it is a very important medicine. Actually,
- 1:45:38it's considered a
- 1:45:39staple medicine by the world health organization. So this is because ketamine
- 1:45:44as a dissociative
- 1:45:45anesthetic is actually very safe. Um, by this, I mean that when we consider things
- 1:45:51like fentanyl or
- 1:45:53morphine, um, or, oh, what's the other one called? Um, it's not propion. Anyways,
- 1:46:01there are other anesthetics that definitely anesthetize a person and make
- 1:46:06them unconscious,
- 1:46:07but the risk of respiratory suppression or other serious medical events, um, under
- 1:46:13the effects of
- 1:46:14these anesthetics is significant. Um, ketamine does not have those same risks,
- 1:46:21at least purely on its
- 1:46:22own. There are risks when it's combined with other respiratory suppressant or
- 1:46:26like, uh, depressant
- 1:46:28agents, but you can generally safely give ketamine to someone who is on the
- 1:46:34battlefield and otherwise
- 1:46:35going to die. For example, in world war one, they gave people morphine. People
- 1:46:40died from the morphine
- 1:46:41directly. Um, in Vietnam, for example, they have ketamine and people would not
- 1:46:46die from the ketamine.
- 1:46:47They'd probably die from their limbs being forcefully removed by explosions perhaps,
- 1:46:52but it wasn't the ketamine that suppressed the respiration. What makes it a staple
- 1:46:58medicine is
- 1:46:58that it's also very cheap to produce and safe to administer. So the world health
- 1:47:04considers it a staple medicine for third world countries because it is such an
- 1:47:08accessible emergency
- 1:47:09medicine. It makes it safe for use in people with compromised, um, medical or
- 1:47:15physiology makes it safe
- 1:47:16for safer, uh, pardon me, uh, for elderly people and even for children. Um, rumor
- 1:47:24has it that China tried
- 1:47:25to get it broadly, uh, criminalized around the world as a part of the sort of like,
- 1:47:30uh, UN sort of agreement
- 1:47:31on what drugs would be criminalized. And it was shot down because the, the world
- 1:47:36health organization
- 1:47:37saw it as such an important medicine. The rumor is that, um, China was trying to do
- 1:47:42this
- 1:47:42because of problems they have with ketamine in their country. Ketamine
- 1:47:46addiction. Don't know that to be
- 1:47:47true. You can look it up if you like. Um, but nonetheless, it is considered as a
- 1:47:51staple medicine
- 1:47:52because of its safety and efficacy. Um, a lot of people call ketamine a, um, horse
- 1:48:01tranquilizer,
- 1:48:02right. Um, and this is because they misunderstand that although ketamine is
- 1:48:09used in veterinary medicine,
- 1:48:10again, because it's a very safe and cheap and accessible anesthetic, that it must be
- 1:48:15like it gets stolen
- 1:48:16from the vets and you're actually getting high on horse tranquilizer, but it's a, it
- 1:48:21as a dissociative
- 1:48:22anesthetic is used broadly across a number of different, uh, domains. Okay. So
- 1:48:28getting into ketamine's
- 1:48:30mechanisms of action, this is pretty complex. Um, and I'm going to do my best,
- 1:48:34uh, to describe it,
- 1:48:36but, um, unlike, uh, unlike DMT, psilocybin, um, MDMA ketamine doesn't
- 1:48:45impact serotonin. I mean,
- 1:48:47it impacts a number of different neural systems, but it's predominant effect is
- 1:48:50what's on the NMDA
- 1:48:52receptor, which is a part of the glutamate system. Glutamate is our main excitatory
- 1:48:58neurotransmitter.
- 1:48:59It tells the brain to go. Um, secondary to glutamate would be GABA. GABA tells the
- 1:49:05brain
- 1:49:05don't go. So that would be our main inhibitory neurotransmitter. When ketamine
- 1:49:11binds to the
- 1:49:13NMDA receptor, it makes it so that in certain areas of the brain, there's an
- 1:49:20increase in glutamate,
- 1:49:22but the area that it binds to is related to the GABA nergic system. So it blocks
- 1:49:29the inhibitory
- 1:49:30effects of GABA. So it increases the excitatory neurotransmitter in the
- 1:49:36prefrontal cortex while
- 1:49:38also inhibiting the inhibitory effect of GABA. You would think that would lead to
- 1:49:44excessive excitation,
- 1:49:45but it seems to make it so that the brain can no longer communicate with itself. The
- 1:49:51way that
- 1:49:51it's selectively acts is that it creates a disrupted connectivity. And since our
- 1:49:59ability to be consciously
- 1:50:00aware is, um, you know, dependent upon our brain communicating with itself in a
- 1:50:06particular way,
- 1:50:06it simultaneously increases mental activity while decreasing, um, the sort
- 1:50:15of, by also detaching
- 1:50:17the brain's connection with the body. This also has to do with how ketamine affects
- 1:50:23the thalamus,
- 1:50:24which is kind of like the brain's relay station. So it cuts off information flow
- 1:50:30to the cortex from
- 1:50:32the body. It disconnects the body's experience from the brain's experience
- 1:50:36while also ramping up
- 1:50:38the brain's, uh, like the prefrontal cortex sort of mental experience. So we
- 1:50:44have this increase in
- 1:50:46sort of subjective experience and a decrease in that experience being tied to
- 1:50:52the sensations of the body
- 1:50:53or even the experience of the body. So you get this disconnection at doses high
- 1:50:59enough. The
- 1:51:00disconnection is so dramatic that the conscious awareness is suppressed
- 1:51:05completely. And despite
- 1:51:06the fact that there might be increased glutaminergic, glut, glutaminergic
- 1:51:10activity, we have no conscious
- 1:51:12awareness at all because we are so like the, the disconnection becomes so great.
- 1:51:18Um, at lower doses,
- 1:51:21we get this weird alteration of the experience. We'll talk about it in a bit,
- 1:51:25but at anesthetic
- 1:51:26doses, we get completely unconscious. However, because of this weird combination
- 1:51:31of increasing
- 1:51:32mental activity while detaching or disconnecting it from body experience or
- 1:51:38sort of like signals from
- 1:51:39the physical body at slightly sub anesthetic doses, we have the experience
- 1:51:45of entering domains of
- 1:51:47experience entirely defined by just mental processing rather than any kind of like
- 1:51:53connection between our
- 1:51:55sensory environment and mental experience. So again, very complex. I don't know how
- 1:52:04well I described it
- 1:52:05there. So I'll let you neuropharmacologists, uh, correct me in
- 1:52:08the comments, but this is the primary action
- 1:52:10of ketamine through the NMDA receptors to disconnect mental experience from the
- 1:52:16body, sometimes to the
- 1:52:17point of unconsciousness, but just before unconsciousness to the point of
- 1:52:21dramatically
- 1:52:22increasing mental experience while completely detaching or dissociating it
- 1:52:27from physical, physical
- 1:52:30experience or the experiences of the body. Now the experience of ketamine itself is
- 1:52:38interesting.
- 1:52:39Very interesting. It can range from mild to significant distortions or dissociation
- 1:52:45from the body.
- 1:52:46So it can alleviate pain, alter physical sensation. It can create a strong
- 1:52:51sensation of feeling floaty
- 1:52:53or even a bit drunk with some mild perceptual distortions. One of the
- 1:52:59aspects, um, and what's
- 1:53:01interesting about this is one of the aspects of it as a, you know, lumbered
- 1:53:05psychedelic experience is
- 1:53:06that whereas things like psilocybin or LSD or MDMA or DMT tend to increase our
- 1:53:15emotional experience,
- 1:53:16ketamine decreases our emotional experience. Our emotions and our feelings
- 1:53:22are tied to our physical
- 1:53:23sensations. They're tied to the signals coming from our physical body into the
- 1:53:28mental or our mental
- 1:53:30experience up in the brain. It's hard not to separate. Like it's hard not to make
- 1:53:36this weird
- 1:53:36separation between brain and body. I mean, brain is obviously a part of the body, but
- 1:53:41the, this
- 1:53:41disconnection that happens makes it so that although we have increased, um,
- 1:53:46mental activity,
- 1:53:46these incredible experiences, and even there could be the sense that there are
- 1:53:51particular feelings
- 1:53:52involved, we don't actually feel them so much. We're dissociated from our feelings.
- 1:53:56This makes it ideal sometimes for certain forms of therapy where you might want to
- 1:54:02go in and work
- 1:54:03on a thing that normally is the feelings of it are too much. But when we're on a
- 1:54:07small enough,
- 1:54:08a dose of ketamine or the right dosage, we can get into it where the feelings no
- 1:54:12longer flood us.
- 1:54:13Now, as this gets into higher doses, the detachment between the physical body's
- 1:54:20sensation or
- 1:54:21perception of the surrounding kind of environment and the mental experience can
- 1:54:26become so dramatic
- 1:54:27that we enter basically phenomenological worlds entirely untethered from the senses
- 1:54:33of our physical
- 1:54:34body, generating out-of-body experiences and seemingly entry into different
- 1:54:40realities,
- 1:54:40ones that can but don't always include autobiographical material, which means we
- 1:54:45can
- 1:54:46enter into other realities that have no sort of sense of being related to our
- 1:54:51history or emergence
- 1:54:52from our memories or anything like that. We're just in totally different worlds,
- 1:54:56spaces within
- 1:54:57possible angles. And even at certain points where the, even the sort of
- 1:55:01relative position of a,
- 1:55:03like a single point of consciousness to the dimensional, like the re the
- 1:55:07dimensions of the
- 1:55:08space that we're in are untied. And there is no single single eyes, local state of
- 1:55:12consciousness,
- 1:55:12at least a local state of awareness, at least as I've had it described to me.
- 1:55:17Nonetheless, when we go into these higher doses that are just below the dosage that
- 1:55:24would create
- 1:55:25unconsciousness, that is when we enter into what one would call a peak
- 1:55:29psychedelic experience on
- 1:55:31ketamine, what other people call the K-hole. K-hole has a derogatory term
- 1:55:36because it really does feel
- 1:55:38like you're sinking out of experience. You like physically, if you've ever seen
- 1:55:43somebody go through
- 1:55:43it, it looks like they're just sinking away. But generally it's called a K-hole
- 1:55:49because most people
- 1:55:50who are using ketamine recreationally are using it, trying to like, just almost like
- 1:55:55being on trippy
- 1:55:56cocaine or something. Like it's stimulating. It's got a dopaminergic
- 1:55:59effect. It kind of like
- 1:56:00engages you, makes things kind of weird. And you want to like, get around and talk
- 1:56:04with people and
- 1:56:04your body feels all strange. I think I had one person describe it to me as like six
- 1:56:08beers on the
- 1:56:09tip of your pinky finger. Um, and then they take too much and they sink away and
- 1:56:14it's a bad thing.
- 1:56:15They call it a K-hole, but people who are more psychonautic recognize that this is
- 1:56:21when well
- 1:56:22contained and you're ready to go in there entering into this K-hole is something
- 1:56:27like entering into the
- 1:56:28peak psychedelic experience of ketamine. Now, one might wonder what it's, you know,
- 1:56:34medical uses. Okay.
- 1:56:36So we have its use as a dissociative anesthetic as a staple medicine. And we
- 1:56:43have the realization that
- 1:56:45it can create these weird psychedelic type experiences. And I already alluded a
- 1:56:50little bit to
- 1:56:51how it could be used in therapy, but what was really curious is that, um, despite
- 1:56:58this ketamine being
- 1:57:00first synthesized in 1962, um, as a safer alternative to PCP, which was being used
- 1:57:06as an anesthetic at the
- 1:57:07time, it was approved for medical use as an anesthetic in 1970. Like I said, became
- 1:57:12widely used as a
- 1:57:13battlefield anesthetic in the Vietnam war. Um, it always had this recognition of the
- 1:57:20psychedelic effects,
- 1:57:21which kind of got it popular and underground use, but generally medically,
- 1:57:24it was still used as an
- 1:57:26anesthetic. This is until in the early two thousands, they discovered that a dose of
- 1:57:33ketamine can
- 1:57:34temporarily, um, lift treatment resistant depression and associated suicidality
- 1:57:42within hours. What this
- 1:57:45means is that they discovered, whoops, that somebody who was suicidally depressed
- 1:57:52and could find no relief
- 1:57:54elsewhere. Somehow given a dose of this anesthetic drug, even at doses that don't
- 1:58:01produce anesthesia
- 1:58:02alleviated their depression and suicidality sometimes for upper two weeks
- 1:58:07before it comes back. Now, besides
- 1:58:10the fact that this, um, created an opportunity to start exploring ketamine as
- 1:58:14an antidepressant drug,
- 1:58:16it opened an entirely new perspective on depression treatment. This is because
- 1:58:21initially depression
- 1:58:23was generally seen as if you've ever heard like the serotonin theory or serotonin,
- 1:58:29um, depletion,
- 1:58:30um, or inadequate serotonin theory of depression effectively that there's not
- 1:58:36enough serotonin in
- 1:58:37the brain. That's why people are depressed. And so they give them SSRI
- 1:58:41select a serotonin reuptake
- 1:58:43inhibitors, which is selectively targeting specific serotonin receptors to prevent
- 1:58:47them from reuptaking,
- 1:58:49which is to clean up the serotonin molecules out of the synaptic cleft. We
- 1:58:53inhibit that we increase
- 1:58:54serotonin in the brain. They see that you increase serotonin in the brain with these
- 1:58:59drugs and people
- 1:59:00are less depressed in a month or two time that goes to stand that, Oh, it must be
- 1:59:06the same increased
- 1:59:06serotonin that creates the antidepressant effects. Now, lots of issues with SSRIs
- 1:59:13and their effects on
- 1:59:14depressions can be anywhere from totally ineffective to very effective to, you
- 1:59:18know, effective, but
- 1:59:19with side effects that make it, people wonder whether or not it's, you know, uh,
- 1:59:24price is worth the,
- 1:59:25it's a gain is worth the cost. But that aside, there's increasing evidence that
- 1:59:31this theory of
- 1:59:33serotonin being the predominant driver of depression is actually false. And that the
- 1:59:37benefits on depression
- 1:59:38we're seeing from SSRIs are not from the serotonin, but as a secondary effect of
- 1:59:43what the increased
- 1:59:44presence of serotonin seems to be doing to neural functioning in general, perhaps
- 1:59:48through glutamate,
- 1:59:49perhaps through neuroplasticity, perhaps through the reduction of stress, who
- 1:59:53knows? Either way, ketamine
- 1:59:55introduced this whole new way of thinking about depression. This drug is, it has
- 1:59:59effects on serotonin,
- 2:00:00but it's not a serotonin drug. It's not, it, it is a drug that is through the
- 2:00:06glutamate system
- 2:00:07producing like anesthesia, dissociative anesthesia. And even if the, there's
- 2:00:12nothing about the experience
- 2:00:13at all that relates anything to depression, people can have reduced
- 2:00:18depressive symptoms for weeks
- 2:00:20afterwards, only after a single dose. That led to a exploration of the role of
- 2:00:27neuroplasticity
- 2:00:28in, in depression, specifically that it seemed as though the rapid increases in
- 2:00:36neuroplasticity that
- 2:00:38ketamine seemed to offer, and how it could help restore synaptic connections in
- 2:00:43regions like the
- 2:00:44prefrontal cortex that show atrophy and depression. It might actually be through
- 2:00:48these neuroplastic
- 2:00:50effects that ketamine is alleviating depression, at least temporarily. So out
- 2:00:56of that, and also because
- 2:00:58ketamine was already legalized, which makes it much more simple to go from it
- 2:01:04being legal to treat one
- 2:01:05condition to it being legal to treat another, rather than with MDMA or
- 2:01:09psilocybin, it is completely illegal.
- 2:01:11And now we have to justify its use broad scale, not just in different conditions.
- 2:01:16It made it so that
- 2:01:17ketamine could be researched and researching its effects on neural tissue
- 2:01:22and on experience into
- 2:01:24other conditions. For example, post-traumatic stress disorder, anxiety
- 2:01:28disorders, even chronic pain
- 2:01:30disorders, as an adjunct to psychotherapy, or even as a just sort of on its own
- 2:01:36thing. People go in and
- 2:01:37they get their IV ketamine and they're under for an hour, and then they come back
- 2:01:40in two weeks when their
- 2:01:41depression comes back. On top of that, it created a whole new emergency medicine use
- 2:01:47for ketamine,
- 2:01:47which is to prevent acute suicidality in emergency medicine. So you can see here on
- 2:01:56the right of the
- 2:01:57screen, on the right of the slide, we've got S-ketamine, which is, so ketamine is,
- 2:02:03I don't remember the term,
- 2:02:05but it, you know, molecules have these two sides. It's like a left hand and a right
- 2:02:11hand. When each of
- 2:02:14these sides is called an enantomer. With ketamine, you have an R side and an S
- 2:02:19side, similar with, if
- 2:02:21you've ever heard of Adderall. So Adderall is a, is a brand name for a selective
- 2:02:28mixture of amphetamine,
- 2:02:29which has a D side dextroamphetamine and L side level amphetamine. And they break
- 2:02:36these two molecules
- 2:02:37apart and they selectively add more of the dextroamphetamine to what otherwise would
- 2:02:41have
- 2:02:41been an even mix, rasmatic and the sort of regular amphetamine. And you get this
- 2:02:46proprietary blend called
- 2:02:47Adderall. With S-ketamine, what we have is the R and the S enantomers broken off and
- 2:02:53just the S side,
- 2:02:54the S ketamine being delivered now as a proprietary drug for the treatment of
- 2:03:01depression through this
- 2:03:02spray. Um, now a lot of people, and I think rightfully so express concern over
- 2:03:12how ketamine
- 2:03:13is finding its way in the sort of psychedelic Renaissance. And it's not
- 2:03:18because people don't
- 2:03:19believe in ketamine as a potential treatment. It is questionable because the
- 2:03:22nasal spray of ketamine,
- 2:03:24ketamine itself can be highly addictive and the nasal spray is a more addictive
- 2:03:27rep. The faster you can
- 2:03:29administer a drug, the higher the developments of dependency and addiction.
- 2:03:33Um, but it's because
- 2:03:36they, the current regulations allow around ketamine, especially in the United States,
- 2:03:41make it very
- 2:03:42easy to start prescribing it for conditions that it's not approved for. And
- 2:03:48with privatized medicine,
- 2:03:49it becomes easy to leverage the popularity of psychedelic medicine, psychedelic
- 2:03:55therapy using
- 2:03:57ketamine, which is technically legal to give to people. Although it's efficacy
- 2:04:02long-term is clearly
- 2:04:03not strong because it usually only lasts for like a week or two. Um, and you end up
- 2:04:10in scenarios where
- 2:04:11people have these boutique clinics that are charging thousands and thousands of
- 2:04:14dollars for people to go in
- 2:04:15and get their ketamine, but they'll have to just keep coming back every two weeks.
- 2:04:18So there's issues of
- 2:04:20dependence, um, profit motives, profit motives will always be something to be
- 2:04:25concerned about in our
- 2:04:26society. Um, at least the way that it's configured now, but these concerns are
- 2:04:33different than with
- 2:04:34psilocybin and MDMA presently, at least. Um, so that's ketamine. You'll have to
- 2:04:40forgive me. Like I said,
- 2:04:41I'm, I'm, I'm doing my best here, but my cognitive function declines, uh, as the
- 2:04:46day goes on pretty
- 2:04:47significantly, there's a steep drop off and I might be in it now, but I think
- 2:04:51we're going to keep going
- 2:04:51and we're going to hope for the best. First, I'll just finish this coffee. Okay.
- 2:04:58So ibogaine, um, ibogaine
- 2:05:01is a naturally occurring indole alkaloid. Uh, like we said, um, an alkaloid, um, the
- 2:05:08indole ring is the
- 2:05:09basis for tryptamine alkaloids. Although ibogaine has a much more complex molecular
- 2:05:14structure than,
- 2:05:15um, the tryptamine alkaloids and has a very different pharmacology. Um,
- 2:05:22essentially tryptamines are also
- 2:05:23indole alkaloids, but not all indole, indole alkaloids or tryptamines. Ibogaine
- 2:05:28as well is also
- 2:05:30a psychedelic under the lumper terminology. Ibogaine is the main
- 2:05:35alkaloid, um, psychoactive alkaloid
- 2:05:38present in the root bark of the Tabernanth iboga plant. Uh, Tabernanth iboga is a
- 2:05:43plant that is
- 2:05:44predominantly, um, present in Africa, West Africa, especially. Um, and although, um,
- 2:05:53we're lumping it in the category of psychedelics for this discussion, it would
- 2:05:58be actually better
- 2:05:59described as an anirogen, which is a compound that facilitates dreams. And the
- 2:06:03reason for this is that
- 2:06:04unlike the kind of like open-eyed psychedelic visual types of things that
- 2:06:13can happen when
- 2:06:14we're under the effects of something like LSD, uh, or, uh, psilocybin, I know we
- 2:06:19didn't talk about LSD,
- 2:06:19but I'm just going to assume that if you know what psychedelics are, you've at
- 2:06:23least
- 2:06:23heard of LSD. Um, Ibogaine, and I don't know this personally because I've never
- 2:06:28experienced
- 2:06:29Ibogaine, uh, at this point in my life seems to create these incredibly immersive
- 2:06:34worlds and these
- 2:06:35scenes that you go into that happened under closed eyes, similar to like being
- 2:06:39in a waking dream,
- 2:06:40but are only present when your eyes are closed. So this is why it might be more
- 2:06:45accurate to describe
- 2:06:45Ibogaine as an anirogen rather than as a psychedelic. But for the purposes of our,
- 2:06:52uh, discussion today,
- 2:06:53we'll call it a psychedelic. The mechanisms by which Ibogaine works is
- 2:06:59incredible. This, um,
- 2:07:02this molecule works on so many different targets in the brain. It works on
- 2:07:06serotonin, uh, dopamine,
- 2:07:07norepinephrine, acetylcholine, glutamate, GABA, OCT2, ion channels, receptor tyrin
- 2:07:14kinases, and
- 2:07:15affects each of these systems in different ways simultaneously. Like it is, um,
- 2:07:23yeah, it's just like an incredibly complex molecule that does things to the brain
- 2:07:28that we
- 2:07:29really don't understand yet how or why it does what it does. Uh, Nolan Williams,
- 2:07:34who I mentioned at the beginning, when I started using the terminology of splitters
- 2:07:39versus slumpers,
- 2:07:40I had him on the show to talk about Ibogaine as a treatment for concussion.
- 2:07:44And we'll talk about that
- 2:07:45in a second, but he used this incredible metaphor. He said, the way that we're
- 2:07:52thinking about how
- 2:07:53molecules affect brain function is the almost like a 14th century key. We think
- 2:07:59about like, oh,
- 2:08:00we use this molecule and it affects these, this particular, you know, neural system
- 2:08:06and it makes
- 2:08:07changes. Um, and that we see it as relatively simple. I mean, we don't see it
- 2:08:11as simple, but like
- 2:08:12our ability to utilize molecules to affect these systems, we're thinking about it
- 2:08:16from a simple way.
- 2:08:17You think about SSRI. It's like, oh, we're going to have these effects on the brain
- 2:08:21by selectively
- 2:08:22targeting specific serotonin receptors and inhibiting a specific function in
- 2:08:27serotonin to create these
- 2:08:28effects. Okay. That's like a 14th century key. He describes Ibogaine as like an
- 2:08:35advanced modern key,
- 2:08:36which it just functions in such a complex way to produce its results that it's
- 2:08:43borderline inconceivable
- 2:08:44between the simplicity of the 14th century key and the modern key. I use the photos
- 2:08:49here that you see
- 2:08:49on the bottom right of the slide where you've got this very simple key, as you
- 2:08:53can imagine, like an
- 2:08:54old skeleton key. And on the right, you have a key for like a modern electric car,
- 2:08:58which is basically just
- 2:09:00a fob and it's got a touch screen. You can control the car's functions like within on
- 2:09:06the key from a
- 2:09:08distance, you know, like the, the difference between these two functions,
- 2:09:10like these two keys and what they
- 2:09:11can do is incredible. You can almost consider something like the difference
- 2:09:15between like
- 2:09:16picking up an old rotary phone to call on the landline and the, you know, cell phone
- 2:09:22in your
- 2:09:22pocket today. Uh, this is like the difference in how complex the mechanisms
- 2:09:26are of these molecules.
- 2:09:27Now, in terms of effects, um, we have, uh,
- 2:09:35closed eye visuals. Um, like I said, close your eyes and it enters into an extremely
- 2:09:40immersive and visual
- 2:09:43experience in your mind's eye, like a dream. Interestingly with, um, ibogaine,
- 2:09:50with iboga,
- 2:09:50with ibogaine, there is what is often described as autobiographical visions,
- 2:09:56sometimes like a life
- 2:09:57review. If you've ever heard the stories of people who die and they go through a
- 2:10:00whole life review from the
- 2:10:02beginning to the end and they go through their whole life and assess all their
- 2:10:05choices and so
- 2:10:05on and so forth. And then they come back with a new perspective, you know, assuming
- 2:10:09they come back to
- 2:10:10tell the tale. Um, ibogaine seems to produce something like this. Some even say
- 2:10:16that there's a spirit there
- 2:10:18that helps guide it and kind of like infirm strongly for us to accept the
- 2:10:22reality of like the consequences of
- 2:10:24our actions and choices as we go through and review our lives and the choices that
- 2:10:28we made and how they've
- 2:10:29contributed to where we are and how the role other people played and how we
- 2:10:33perceive ourselves in the
- 2:10:34world. And that this is a, is a, is a quintessential part of the ibogaine
- 2:10:39experience. They can also be
- 2:10:42incredibly challenging. Like all psychedelic substances can be challenging.
- 2:10:45Even MDMA can be challenging,
- 2:10:46despite how like lovey-dovey and pleasant it can feel. It can also have overwhelming
- 2:10:50and challenging
- 2:10:51aspects. But ibogaine is particularly uniquely challenging. It is incredibly
- 2:10:57long lasting.
- 2:10:58You know, we can think of LSD as lasting a very long time at like, you know, 10-ish
- 2:11:03hours. Well,
- 2:11:03ibogaine can last 24 hours up to 30 hours. And in that timeframe, any kind of
- 2:11:10movement can contribute to
- 2:11:12nausea or vomiting or just like retching and discomfort. And this can go on for a
- 2:11:17very long time.
- 2:11:18So because of this, outside of certain circumstances and cultural scenarios at
- 2:11:23very low doses,
- 2:11:25there's little to no recreational use of ibogaine. It's predominantly used in
- 2:11:30ceremonial or therapeutic settings. And on top of that is the only psychedelic,
- 2:11:35quote, psychedelic, whose physiological effects can directly result in death.
- 2:11:42Now it is okay. So outside of MDMA, which could cause death in the scenario of
- 2:11:48what's called
- 2:11:48serotonin syndrome, you have too much MDMA, for example, or it's mixed with the
- 2:11:53wrong substances.
- 2:11:54And you have such an increase of serotonin that you can't regulate. You go into
- 2:11:59what's called
- 2:11:59hyperthermia. Your body can't regulate its temperature and you basically start to
- 2:12:04burn up
- 2:12:04and then your brain fries out and you vomit yourself to death. It's terrible.
- 2:12:09People do die
- 2:12:09that way with MDMA and it's very sad. But with other psychedelics, sure, people
- 2:12:14could die by making
- 2:12:15terrible choices while they're under the influence, hurting themselves or walking
- 2:12:20out into traffic.
- 2:12:21But the psychedelic effects don't directly cause death. Like you don't do like the
- 2:12:27LSD doesn't kill
- 2:12:28a person. Psilocybin doesn't kill a person. Someone could die as a consequence
- 2:12:33of the choices they make
- 2:12:33on it, but it's not direct. Ibogaine isn't like that. There's a possibility that
- 2:12:40because of how ibogaine
- 2:12:41affects cardiac functioning, it slows the heart rate down so slow, sometimes as low
- 2:12:49as 50 beats a minute,
- 2:12:51it's very slow, that if a person has an irregularity in what's called their QT
- 2:13:00interval, which is the
- 2:13:01interval between heartbeats, if there's an irregularity there, ibogaine can produce
- 2:13:06what's called
- 2:13:06Torsod syndrome where the heart doesn't start beating again. It slows down so much
- 2:13:13that in
- 2:13:14between beats it just stops. Now the actual record we have of people dying
- 2:13:20through Torsod syndrome,
- 2:13:21through ibogaine is sparse and pretty much every single example was because there
- 2:13:27wasn't good medical
- 2:13:29screening in advance or that person was already very ill because a lot of the
- 2:13:33people who we have
- 2:13:33have a history of taking ibogaine outside of its traditional uses in Africa, which
- 2:13:38we'll talk about
- 2:13:39in a second, generally is people who are undergoing long periods of addiction.
- 2:13:44We're going to talk about
- 2:13:45that in a sec. Nonetheless, it's the only psychedelic that can directly result in
- 2:13:51death.
- 2:13:52Something else that I wanted to mention about the experience that's unique is that
- 2:13:57on top of going
- 2:13:58through autobiographical visions, it also seems to increase like there's a high rate
- 2:14:05of people
- 2:14:05encountering what they would call their ancestors or communication with dead loved
- 2:14:10ones. Happens on
- 2:14:11other psychedelics as well, but it seems to be something unique about ibogaine and
- 2:14:16that the connection
- 2:14:18with ancestors and dead loved ones is a part of this life review unique to
- 2:14:22ibogaine.
- 2:14:24Okay, so let's talk about ibogaine's history. So ibogaine's been used by
- 2:14:32centuries by the Bwiti
- 2:14:34people of West Africa in initiation and ceremonial practices. Now, mind you,
- 2:14:38they're not using ibogaine,
- 2:14:39they're using the root bark of the Tabernanth iboga plant, they're using
- 2:14:43iboga. But it has been a part of
- 2:14:45their traditional history for hundreds of years. In 1901, ibogaine was first
- 2:14:52synthesized by French
- 2:14:53researchers and was actually at one point sold as a stimulant in France in the form
- 2:14:59of what was called
- 2:14:59lambarine. And speaking of recreational purposes, it was for a while sold in
- 2:15:09France as a recreational drug
- 2:15:11from 1930s to 1960s. And it was only withdrawn from the market when ibogaine
- 2:15:16itself was made illegal by the French
- 2:15:18government in 1966. Now, when I mentioned before about how the people, oftentimes
- 2:15:26people outside of
- 2:15:27traditional context who are taking ibogaine end up being people who have
- 2:15:31spent long periods of time in addiction.
- 2:15:33This is because in 1962, a man named Howard Lotsov accidentally discovered its
- 2:15:39anti-addictive
- 2:15:40effects. Effectively, if I remember this correctly, they used heroin and they tried
- 2:15:48ibogaine as like
- 2:15:49a new kind of drug that they wanted to like try out that they're experimenting
- 2:15:53with. And they came out on
- 2:15:54the other side of that, where their dependence, which is physiological, their
- 2:15:59need for heroin and
- 2:16:00their addiction, the sort of non-physiological, the psycho-emotional,
- 2:16:05social, um, aspect of addiction
- 2:16:08was gone. And since then he, and then he started to offer to others and it got to a
- 2:16:16point where it
- 2:16:16became on the underground, a way in which people could get off heroin, get off
- 2:16:21opiates that they were
- 2:16:22addicted to. And even now it is the only drug that we know of that can effectively
- 2:16:27stop opioid withdrawals
- 2:16:29within a few hours of administration. And in a supportive context, it makes it so
- 2:16:34that people come out the
- 2:16:35other side of it for the most part, no longer physically dependent on the opiate
- 2:16:39and no longer
- 2:16:41addicted. And part of that being the life review, the autobiographical review that
- 2:16:46they go through and
- 2:16:47how that changes their relationship to the substance. Now, this isn't a solution to
- 2:16:51addiction,
- 2:16:52but it, people can still go back in and end up back on heroin, of course, but it's
- 2:16:58incredible
- 2:16:59that the effects that we have mostly anecdotally, because we don't have a lot
- 2:17:03of good, um, medical
- 2:17:05research on its anti-addictive effects. We have incredible amounts of anecdotal
- 2:17:11evidence on its
- 2:17:12ability to stop opioid addiction, to cease the addiction, to cease the dependence and
- 2:17:17give people a
- 2:17:17new lease on life. And primarily that is where iboga, um, ibogaine treatment sort
- 2:17:25of rests in the larger
- 2:17:26scheme of psychedelic research, um, is mostly, uh, treatment centers that operate
- 2:17:31in countries where
- 2:17:31it's legal, where they're predominantly targeting addiction. Although research
- 2:17:36into its mechanisms and
- 2:17:37different uses continues, such as, um, with head injury, we'll talk about in a
- 2:17:42second. Um,
- 2:17:43and of course there's still an underground, there's still, um, a bit of a
- 2:17:48tourist, you know,
- 2:17:50psychedelic tourism, uh, industry for going to countries like Gabon to have a
- 2:17:54true, what's called
- 2:17:55a traditional Buitia initiation, non tourism, like genuine spiritual initiation
- 2:18:00there for people who
- 2:18:01aren't necessarily African. Um, and there's underground, um, there's
- 2:18:06underground networks
- 2:18:07of people using ibogaine for a more spiritual or therapeutic PTSD and so on
- 2:18:11and so forth, not just
- 2:18:12addiction. So it exists in the underground for a wide, um, dynamic of uses the same
- 2:18:18as ayahuasca might,
- 2:18:19although admittedly to a different degree of, of presence. Um, but primarily a lot
- 2:18:27of it is
- 2:18:29for addiction. Now, when we look at ibogaine's, um,
- 2:18:34medical, uh, medical uses, like I said, we have the anti-f anti-addictive effect in
- 2:18:43the aftermath
- 2:18:43of the ibogaine experience. People go in addicted for heroin for 15 years and face
- 2:18:48everything in their
- 2:18:48lives that led them to that addiction and all that came out of it. And then the
- 2:18:51eggs, the experience
- 2:18:52physiologically cleaned up the drug and empowered to change their lives away from
- 2:18:57that addiction after
- 2:18:58only a single session. We have no other drug that does this. The best option that
- 2:19:02we have right now
- 2:19:03as a medical institution in at least North America is to help people get off opiate
- 2:19:10drugs by putting
- 2:19:10them on another opiate drug that they're dependent on, which is effectively
- 2:19:14methadone treatment.
- 2:19:15Um, the, um, um, the ability to have a drug that can clear people of this
- 2:19:23addiction is incredible.
- 2:19:25It's just complicated because, well, people could die. It's a 30 hour
- 2:19:31psychedelic experience. There's,
- 2:19:33there's a lot of complexities that prevents it from being more present, um,
- 2:19:37in our medical institutions,
- 2:19:38despite the data that we have on it. Um, we, so let's see, we've got, uh, we've
- 2:19:46discussed non-opioid
- 2:19:47drug. Oh, and it's a non-opioid drug, um, that can stop opioid withdrawal symptoms,
- 2:19:52reverse opioid
- 2:19:53tolerance, um, or dependency, free, seemingly free, quote, free people of
- 2:19:58addiction. Now, the other thing
- 2:19:59that is interesting is that, uh, research in the last few years, particularly
- 2:20:03through Nolan,
- 2:20:04Williams and Stanford have found that, um, treatment with Ibogaine can help reverse
- 2:20:12TBI,
- 2:20:13mild traumatic brain injury or concussion. Effectively, we have these people going
- 2:20:19in,
- 2:20:19predominantly they're veterans and they all have concussion use blast injury. I
- 2:20:25believe they were
- 2:20:26all in the mild category. And I want to clarify that a mild TBI traumatic brain
- 2:20:32injury doesn't mean
- 2:20:33mild in impact. It just means that there isn't any like traumatic damage to the
- 2:20:39brain, like a moderate
- 2:20:41to severe, you could go through a, you know, a CAT scan and you could see like
- 2:20:44pieces of the brain are
- 2:20:45just gone. You know, like that's a severe, um, severe, uh, brain injury. You have
- 2:20:52when it's like
- 2:20:53moderate brain injury, you can see damage, a mild, um, traumatic brain injury is that
- 2:20:59you can't really
- 2:21:00see the damage outside of very specialized, highly expensive equipment,
- 2:21:03like a functional MRI. Um,
- 2:21:06but you can track the damage through its functional consequences. So somebody
- 2:21:12being, uh, having reduced
- 2:21:16cognitive energy or reduced ability to communicate or sensory challenges, or one
- 2:21:22of the hallmarks of TBI
- 2:21:23or concussion is not just, you know, cognitive functional challenges, but
- 2:21:29emotional dysregulation,
- 2:21:30increased rates of depression, increased rates of suicide. It's hard to live with a
- 2:21:36brain injury,
- 2:21:36um, in a lot of ways, especially hard that people don't really see it on the outside.
- 2:21:42Um,
- 2:21:42unlike a broken leg in the cast, you could tell how much that impacts someone's life.
- 2:21:46But if they're,
- 2:21:47somebody is talking mostly normally, you have a good reason to assume that they're
- 2:21:50probably mostly fine.
- 2:21:51And that is not always the case anyways. Um, so, um, try not to get too personal
- 2:21:58about this here.
- 2:21:59Um, you have these individuals that are going in to these, uh, experiences, people
- 2:22:06who have been with
- 2:22:07their concussion for more than two years, and they all through a number of different
- 2:22:11sort of like, um,
- 2:22:14wasn't willing for like surveys that would track disability status. They all qualify.
- 2:22:19This person is
- 2:22:20qualifiably disabled by their concussion. They go in, they have their ibogaine
- 2:22:27experience. They come out
- 2:22:28the other side, same metrics, same surveys. They no longer qualify for
- 2:22:33disability. And that this sustains
- 2:22:36for at least a year, we have no other drug whatsoever. We have at best guesses and
- 2:22:44compensations that can help people after mild traumatic brain injury, after a
- 2:22:48concussion kind of
- 2:22:49get back some of their function and try to rehabilitate as much as possible. But for
- 2:22:54a lot of people,
- 2:22:55especially if they've had multiple concussions, it just gets to a certain
- 2:22:59point and it just doesn't
- 2:23:00get better. And there's nothing we can do. There's no pharmacological treatment we
- 2:23:03have
- 2:23:04to help get their brain back to healthy. And it seems like ibogaine does this in a
- 2:23:11single session
- 2:23:12and it sustains for at least a year. And last I heard it was still sustained after
- 2:23:16two years since
- 2:23:17this research, they can even look, they did, like I said, it's a very
- 2:23:22sophisticated, highly expensive
- 2:23:23imaging, functional magnetic resonance imaging that can show changes. Like you
- 2:23:27could see like, okay,
- 2:23:29here is where that brain, here's where that injury is before the ibogaine, after
- 2:23:33the ibogaine, it's gone
- 2:23:34after a single session. And we just don't have any other doctor to do this. It's,
- 2:23:43it's absolutely incredible. One of the comments I heard was something like it can
- 2:23:48de-age the brain by
- 2:23:49two years or one point some odd years as well. I'll let you just research that
- 2:23:53yourself because it's
- 2:23:54very curious to think that if aging as a natural sort of sort of degradation of
- 2:24:01brain function as
- 2:24:02a natural consequence of molecular operation over time, you know, uh,
- 2:24:09basically aging causes this
- 2:24:11damage and ibogaine seems to reduce and reverse some of that damage. I mean,
- 2:24:15there's obviously the
- 2:24:16concussion stuff here, but then there's the other question of just like the idea
- 2:24:20of de-aging the brain.
- 2:24:21And most recently that I heard, at least as of last year, is that they showed it as
- 2:24:27potential treatment for multiple sclerosis. Effectively that ibogaine seems
- 2:24:31to reduce the
- 2:24:32presence of the lesions that multiple sclerosis has in the brain. So multiple
- 2:24:36sclerosis generates
- 2:24:37these lesions on the brain. That is a part of it as a, as a, as a disease. And
- 2:24:44ibogaine seems to reduce
- 2:24:45those lesions. So here we have this molecule from this ancient plant. I mean,
- 2:24:52all plants are ancient,
- 2:24:53that has this incredibly advanced pharmacology that we're barely even, that
- 2:25:00not only are we barely
- 2:25:01scratched the surface of how it works, but like it reveals things about the
- 2:25:04inter-functionality
- 2:25:05of the brain that is, you know, itself beyond what we already understood. Pushing
- 2:25:11our, pushing our
- 2:25:12understanding of, of basically how we can selectively target, uh, functions within
- 2:25:17the brain through
- 2:25:18pharmacology. And it does these amazing things that we have no other treatments
- 2:25:22for. Incredible.
- 2:25:25Um, so those are the psychedelics we talked about today. We talked about, uh,
- 2:25:31ibogaine. We talked
- 2:25:32about ketamine. We talked about MDMA. We talked about DMT. We talked about
- 2:25:35psilocybin. A couple of
- 2:25:38notable mentions that we did not talk about. Clearly this is already a very long
- 2:25:41podcast, a very long
- 2:25:42lecture. We did not talk about 5-MeO-DMT, which is similar to NM-DMT, except it does
- 2:25:49not produce
- 2:25:50incredibly complex, vivid experiences, but instead, or like visual experiences, but
- 2:25:55instead produces what
- 2:25:57might, some might call like a complete absence of sort of subjective content. Um,
- 2:26:04that instead of the
- 2:26:05highly colorful dimensional reality of other entities and beings that NM-DMT can
- 2:26:09take you into, 5-MeO-DMT
- 2:26:11seems to take people into a place where there is an absolute absence of anything.
- 2:26:18Entities,
- 2:26:19beings, beings, even the self that people sometimes call it the God molecule,
- 2:26:23because
- 2:26:24people enter into states where all of time collapses into one singular being. That
- 2:26:32is, I am everything.
- 2:26:34I am that I am. Cool. Haven't experienced it. Seems interesting. Didn't talk about
- 2:26:40it. LSD, um,
- 2:26:44mentioned it a few times, huge history, huge cultural impact. Um, definitely worth
- 2:26:51researching
- 2:26:51on your own. Uh, mescaline as well. We didn't talk about mescaline as the active
- 2:26:55molecule in the various
- 2:26:56psychedelic cacti, such as mescaline, uh, sorry, mescaline, such as peyote, um, or,
- 2:27:02um, things like, uh,
- 2:27:03San Pedro, Echinopsis patinoy. Uh, we did not talk about salvia, 5-MeO-DMT, LSD,
- 2:27:10mescaline. These are all
- 2:27:11classical psychedelics. We did not talk about salvia, which also has psychedelic
- 2:27:14like effects, but is,
- 2:27:15this operates on the opioid system in particular, the Kappa opioid system. Um,
- 2:27:21and we did not talk
- 2:27:23about Amanita muscaria mushroom, uh, a mushroom that would also not qualify as a
- 2:27:28psychedelic, uh,
- 2:27:29on the splitter terminology, but is increasingly interesting, um, in its, in
- 2:27:35its on, in its growing
- 2:27:36presence of use in the underground, specifically through microdosing and some
- 2:27:40of the clinical research
- 2:27:41coming up very sparse, but early days, um, and its benefits on neurological function
- 2:27:46and mental health.
- 2:27:46And we didn't talk about Datura, which in many ways we just wouldn't, uh, because
- 2:27:53people don't talk
- 2:27:54about Datura or the, what's called the tropane alkaloids or the deliriance when
- 2:27:58we talk about
- 2:27:58psychedelics. Cause for the most part, outside of utilizing one specific molecule
- 2:28:03out of Datura,
- 2:28:05scopolamine as a, you know, clinical model for like Alzheimer's and dementia, because
- 2:28:10it's so
- 2:28:11effectively knocks out the ability to like form memories. Um, Datura is like way out
- 2:28:16there,
- 2:28:16like historical uses included, like, um, necrophilia and all sorts of weird stuff.
- 2:28:24at least, okay, don't propagate that. This is what I understand, but I don't want to
- 2:28:28support rumors that aren't true, but nonetheless, Datura is like weird. And I
- 2:28:32would only talk about
- 2:28:33it just because of how weird it is, not because it necessarily applies under
- 2:28:36psychedelics, but it does
- 2:28:36have traditional use. Um, now we're pretty far in, but I want to talk quickly about,
- 2:28:44um,
- 2:28:45why it is that psychedelics seem to have, um, all these different effects on all
- 2:28:52these different
- 2:28:52systems. Like we talked about how Ibogaine seems to have at least what we can see
- 2:28:56these three potentials,
- 2:28:57addiction, um, uh, addiction, um, TBI, MS, talked about ketamine with depression. And
- 2:29:08through that
- 2:29:08psychotherapy, we talked about some of DMT for depression and brain regeneration and,
- 2:29:14uh, also,
- 2:29:15um, psilocybin for a number of different things. But outside of this, we're
- 2:29:19learning that psychedelics
- 2:29:20seem to be able to do similar things on the output. Like it could, they can treat
- 2:29:28similar
- 2:29:28things very effectively and they can treat a dynamic of different things. So despite
- 2:29:33very
- 2:29:34different mechanisms underlying the different psychedelics we spoke of today,
- 2:29:38they all share
- 2:29:39common characteristics, um, that make them able to address these so many different
- 2:29:45conditions,
- 2:29:45different mental health conditions, different neurological conditions, and
- 2:29:50supporting sometimes
- 2:29:51medically unexplainable recovery. Um, now those mechanisms that are generally shared
- 2:29:57across all of
- 2:29:58them is decreases in neural inflammation. So we talked earlier about how neural
- 2:30:03inflammation can have
- 2:30:04a detrimental effect on brain rehabilitation, and it can also cause
- 2:30:08degradation of neural tissues,
- 2:30:10basically neuronal death through oxidative stress. Um, and that all of the
- 2:30:15psychedelics seem
- 2:30:15to reduce neural inflammation, which would theoretically at least reduce damage and
- 2:30:20increase the likelihood
- 2:30:21of rehabilitation. But on top of this, they also seem to all in some way or
- 2:30:25another increase
- 2:30:26neuroplasticity and perhaps neurogenesis. Effectively, now we've sort of put the
- 2:30:31fire down,
- 2:30:32allowed rehabilitation to happen, producing further damage, protecting from
- 2:30:35further damage,
- 2:30:36while also giving on the neurological level, the opportunity for people to
- 2:30:41create new pathways or utilize the
- 2:30:44pathways that are there in their firing differently to allow rehabilitation, be it
- 2:30:49through mental illness,
- 2:30:49or, you know, learning how to move your arm again after stroke, whatever it might
- 2:30:53be, um,
- 2:30:55such that we can lay new foundations for how the brain works such that it can not
- 2:31:00only heal itself,
- 2:31:01but we can functionally redevelop capacities in life, be them mental,
- 2:31:06emotional capacities, or physical
- 2:31:08and with terms of neuro neurogenesis. And with terms of neurogenesis, perhaps even
- 2:31:13generating new neurons in
- 2:31:15different areas in the brain, which would allow, of course, for further networking
- 2:31:20scaffolding to happen
- 2:31:21if we have new sort of like, uh, you know, uh, points upon which that we can link
- 2:31:26networks together, new, uh,
- 2:31:29centers, uh, for connection. They also all support psychological flexibility. We've
- 2:31:35been talking about, uh, the neurological side of things
- 2:31:38here. Um, but on the psychological side of things, they produce the ability to think
- 2:31:44differently,
- 2:31:44to respond differently, to go in and look at aspects of ourselves or our lives or
- 2:31:51our experiences
- 2:31:51or our perspectives that normally would be locked and shift those things to respond
- 2:32:01differently to what
- 2:32:02otherwise would have triggered a very typical response in us to change our
- 2:32:06opinions on ourselves,
- 2:32:07to change our beliefs about ourselves, believe our change are the models in which
- 2:32:12with which we define
- 2:32:13what self is relative to other. This kind of psychological flexibility is absolutely
- 2:32:19in making any kind of change in life, especially when it comes to making changes
- 2:32:23in our mental health,
- 2:32:24which is one of the reasons why it can be so if they can be so effective in a bunch
- 2:32:28of different
- 2:32:28mental health conditions and even on a spiritual or sort of non psychiatric
- 2:32:34therapeutic place in our
- 2:32:36lives to make changes to better our lives and better ourselves. They also support
- 2:32:41placebo and
- 2:32:42placebo can be a bit of a dirty word. Um, it often is used to infer like not real or
- 2:32:49that's not actually
- 2:32:50happening. But, um, an interview I did with Jim Fadiman and Jordan Gruber who
- 2:32:55wrote a book about,
- 2:32:55um, micro dosing. They talk about, uh, basically how we misunderstand placebo and
- 2:33:00how important it is to
- 2:33:01understand what it is to support the placebo process. I'll leave a link. Um,
- 2:33:06they talk about,
- 2:33:07and I, and I agree is that the placebo effect basically is to say we have a
- 2:33:13positive effect that
- 2:33:14isn't necessarily tied to like physical intervention. So if someone takes a sugar
- 2:33:21pill and they get better,
- 2:33:22you don't go, Oh, well that doesn't count because it was just a sugar pill. Like we
- 2:33:27go, Oh damn,
- 2:33:28something about the change in their mind produced a positive output to say that
- 2:33:35psychedelics support
- 2:33:36the placebo effect is not to say that psychedelics are placebo. They're clearly
- 2:33:39not. There's absolutely
- 2:33:41effects happening and we can track them exactly to like, this is happening and
- 2:33:45here's their outcome
- 2:33:46psychologically and neurologically, but they can support the placebo effect in the
- 2:33:50sense that
- 2:33:51the changes that they engender in neuroplasticity and neurogenesis and
- 2:33:55psychological flexibility
- 2:33:56and neuroinflammation make it. So whatever it is that under writes, the placebo
- 2:34:03process that allows
- 2:34:04people to change their mind and generate greater health as a consequence, seemingly
- 2:34:09untied to the
- 2:34:10direct effects of the physical molecule that we're imbibing. It supports that, or
- 2:34:16at least it can.
- 2:34:16And finally, they all have the, um, central mechanism of what I call
- 2:34:23experiential medicine.
- 2:34:24In this sense, we see say medicine, not as the molecule itself, but as like the thing
- 2:34:31that heals.
- 2:34:32Medicine is the thing that heals and experiential medicine is the experience
- 2:34:36itself can be healing.
- 2:34:37You know, if we just completely let go of all of the neurological possibilities, all
- 2:34:41the sort of
- 2:34:42neurological correlates of healing that can happen. If I am in an experience where
- 2:34:48I am able to
- 2:34:50directly connect with, to directly experience, I'm okay. Life is beautiful.
- 2:34:59And before that, the only thing I could experience is I'm not okay. Life is awful
- 2:35:05and I hate myself and I
- 2:35:06hate my life and I want to die. And I have the experience. It doesn't, none of the,
- 2:35:11none of the
- 2:35:12neurological stuff matters in this sense. You know, if I just have the experience,
- 2:35:15the deeply lived
- 2:35:17experience for a moment of it being absolutely true that I'm okay and life is
- 2:35:22beautiful and life is
- 2:35:23worth living. That experience itself is medicine. So that's kind of an extreme
- 2:35:29example, but all of
- 2:35:30these psychedelics share the common central mechanism of also experiential
- 2:35:35medicine generating experiences
- 2:35:37that themselves can be healing. So, um, that's it. Wow. Almost three hours guys.
- 2:35:46Holy goodness.
- 2:35:47I hope that this didn't fall off a cliff halfway through and that you're still
- 2:35:50listening.
- 2:35:50Um, but to summarize psychedelic compounds, including the quasi
- 2:35:56psychedelics of ibogaine,
- 2:35:56MDMA and ketamine are powerful psychoactive agents that are poised to
- 2:36:00transform our understanding of
- 2:36:02mental health, psychiatric medicine, and perhaps even that of consciousness itself.
- 2:36:07Close. End of lecture. Three hours. Probably I haven't gone back to do any
- 2:36:14editing. There'll be a
- 2:36:15couple of cuts there. Um, after my break, I really started to have a hard time with
- 2:36:20my cognitive function.
- 2:36:20Um, so I had to repeat things. Um, and I don't want to subject subject you to that.
- 2:36:27Anyways, that's it.
- 2:36:29Um, I have been studying psychedelics very rigorously. Um, and literally at previous
- 2:36:38times in my life before,
- 2:36:39uh, my accident traveled around the world, learning from others, sitting in different
- 2:36:44ceremonies and different
- 2:36:44cultures and speaking with people above and underground around psychedelic
- 2:36:48research and culture.
- 2:36:50And it is something I care about. I think it's something that's important to the
- 2:36:53world.
- 2:36:54Hopefully it was important to you. And, uh, what you heard today is sort of little
- 2:36:58piece of what I
- 2:36:59have learned over that time. Um, and, uh, in the hopes of sharing it with you to
- 2:37:04increase your
- 2:37:05understanding of psychedelics, strong possibility that I got some things wrong.
- 2:37:09Um, and if I got those
- 2:37:11things wrong, please let me know in whatever comments you can. Um, I will, I
- 2:37:15can't go back and change it
- 2:37:16once it's posted, but I can definitely highlight those comments and add
- 2:37:20editorial, uh, notes in the
- 2:37:22podcasts, um, show notes, which will be at jameswgesso.com. Please check it out. And,
- 2:37:31of course things change science is beautiful in the sense that things that we
- 2:37:36once believed to be
- 2:37:38probably true can be later proven to be absolutely false and new things can be
- 2:37:42true. And psychedelics
- 2:37:43are an incredibly, uh, rapidly advancing field. Um, and I'm so excited for what's
- 2:37:50coming down the pipeline.
- 2:37:53That's all. Uh, I don't want to belabor this too much further, but, uh, if you did
- 2:37:57find this value,
- 2:37:57please consider engaging it online in some way, likes, comments, uh, subscriptions,
- 2:38:03follows. Um,
- 2:38:04I'll be posting clips of this on YouTube and on Instagram, where I primarily post
- 2:38:09clips. You can
- 2:38:10follow me through my newsletter, through blue sky, Twitter, Instagram, all of that
- 2:38:15will be in the show
- 2:38:16notes or in the description of this episode. Um, I also have a sub stack,
- 2:38:20which I have not started
- 2:38:21working on yet. It's there. So follow me in advance. And at some point in the
- 2:38:25you'll get a notification that I'm doing something that hopefully you will think is
- 2:38:27cool. And if you
- 2:38:28don't, you can unsubscribe, no harm, no foul. Right. Um, and, uh, I think that's
- 2:38:36it. Um, did I already
- 2:38:38ask you to support the show, support it financially through a donation or becoming
- 2:38:41a patron would love
- 2:38:42that, um, makes a huge difference. And, um, I say this at the end of, of all of
- 2:38:50the talks that I've
- 2:38:50given, and I think it's important. I don't say it at the end of the podcast super
- 2:38:53often. Um,
- 2:38:55but I mean it now when I say it, and I mean it every time, even if I don't say
- 2:38:59it, which is that
- 2:39:00it is no small gift to be offered someone's attention for hours, even for
- 2:39:11five minutes.
- 2:39:11But if you're listening to this now, and you're this far in, you offered me your
- 2:39:15attention for
- 2:39:15literally hours. Thank you. I don't take that for granted. Not only are there so
- 2:39:23many other
- 2:39:24things that you could conscientiously give your attention to, there are also even
- 2:39:28more things that
- 2:39:28are like through design attempting to steal your attention towards them. And yet
- 2:39:35you chose to listen
- 2:39:36to this. And I thank you for that. And I hope that it proves to be valuable in your
- 2:39:40life. And, um,
- 2:39:41I hope, I hope you are well from here. And, uh, this has been episode episode 200
- 2:39:49of adventures to
- 2:39:49the mind. We're going back into normal interviews from here. If you've liked this
- 2:39:53format, you want
- 2:39:53to hear me do more of this stuff, let me know. Um, but otherwise we're back, uh,
- 2:39:58for some straight
- 2:39:59up regular interviews from here. Uh, and, uh, I'm rambling again. I'm tired. I think
- 2:40:07I need another
- 2:40:07nap. Um, that's all. Thank you so much. And until the next episode of adventures
- 2:40:13of the mind,
- 2:40:14take care and stay curious.